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CHAPTER ONE. INTRODUCTION 
DISSERTATION ORGANIZATION 
 This dissertation follows the organizational format in which the experimental chapters 
of the thesis are prepared in manuscript format.  The first chapter of the thesis outlines 
background information and serves as an introduction to the experimental chapters.  
Experimental chapters two, three, and four either have been submitted or will be submitted to 
peer reviewed journals for a total of three publications.  The final chapter five, ties together 
the findings of the experimental chapters and discusses the results as it relates to the 
problems outlined in the first chapter. 
 
LITERATURE REVIEW 
 
Myeloid Lineage Immune Cells 
 
Origination, Function and Characterization 
Myeloid cells are derived from hematopoietic stem cells differentiated from the 
medulla ossium rubra or red marrow region within the bone marrow. Some of the 
hematopoietic cells of the red marrow develop into monocytes allowing them to leave the 
bone marrow barrier into the medullary blood vasculature entering circulation (39, 177). 
Granulocytes such as neutrophils, eosinophils, and basophils are generated through related 
but divergent developmental pathways (42). Although partially differentiated, peripheral 
blood monocytes are an immature immune cell that can further develop into various tissue 
macrophages (MΦ) and dendritic cells (DCs), which occurs after extravasation and 
infiltration into tissues (6). Monocytes arbitrate host antimicrobial defense by secreting 
cytokines and antimicrobial peptides through chemotaxis mediated by receptors CCR1, 
	   2	  
CCR2, CCR4, CCR5, CX3CR; and ligands monocyte chemoattractant protein (MCP)-1 
(CCL2), regulated on activation normal T expressed and secreted protein (RANTES) (CCL5), 
IL-8 (CXCL8), macrophage inflammatory protein (MIP)-1α/β (CCL3/4), MCP-2 (CCL8) 
(174). Additionally, monocytes can be recruited into tumor sites and potentially mediate 
some aspects of anti-tumor immune response through release of arginase or restricting 
vascular endothelial growth factor (VEGF) stimulation of vasculogenesis and angiogenesis 
(150).   
The surface marker CD14 is highly expressed on monocytes, and has functional 
properties important in the binding of LPS in the context of LPS-binding protein and co-
localization to the TLR4 signaling complex (20). CD16 is a low-affinity Fcγ receptor 
(FcγRIII), which is important in binding to and recognizing IgG and is expressed on some 
subsets of monocytes (212).  Likewise expression of CX3CR1, a transmembrane molecule 
important in migration, and CCR2, the receptor for MCP-1, can be used to delineate 
peripheral blood monocyte subpopulations in the naïve animal (177). This leads to a 
classification system in humans and mice comprising three groups: classical, intermediate 
and nonclassical. Classical monocytes are CD14hi (or referred to as CD14++) absent in 
expression of CD16 (CD16–), CCR2hi, CX3CR1lo. These classical monocytes are pro-
inflammatory and resemble LY6Χ monocytes in mice based on transcriptional analysis (63, 
91, 186).  Intermediate monocytes are CD14++, CD16+, CX3CR1hi, CCR2lo and contribute to 
a proinflammatory response (13, 218). Non-classical monocytes are CD14+, CD16++, 
CX3CR1hi, CCR2lo (174) and are important for anti-viral mediated responses and local 
surveillance of tissue (43). This classification system has been established for human and 
mice monocyte populations, although a bovine classification has not been delineated (86, 
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218).  CD14+, CD16- monocytes are the predominant phenotypic blood monocyte of cattle 
and are believed to be homologous to classical monocytes in humans (86, 204, 207).  
As monocytes infiltrate into tissues, they become monocyte-derived MΦ or MDMΦ.  
During infiltration and maturation these cells undergo phenotypic changes such as an 
increase in surface expression of CD14, CD11b (MAC-1), CD32 (FcγRII), and major 
histocompatibility complex (MHC) class II (207).  MΦ can respond to extracellular cytokines 
to become activated.  Activation signals of IFNγ and LPS will induce  “classical” activated 
MΦ, which produce proinflammatory cytokines IL-12, IL-1β, IL-6, TNFα, proteolyic 
enzymes matrix metalloproteinase (MMP)-1, MMP-2, MMP-7, MMP-9, MMP-12, and an 
increase in arginase, reactive oxygen species (ROS) and nitric oxide (NO) production (209).  
Likewise, “alternative” activated macrophages respond to IL-4 or IL-13 signaling and 
produce an anti-inflammatory response by promoting repair of the extracellular matrix 
(ECM) and production of IL-10 and TGFβ.  MDMΦ are important in recognizing innate 
recognition signals or pathogen associated molecular patters (PAMPs) to initiate an immune 
response (94, 137). One type of pattern recognition receptors (PRRs) are the toll like 
receptors (TLRs).  As MDMΦ differentiate from monocytes, TLR expression increases and 
MDMΦ demonstrate an enhanced response to stimulation by an increase in IL-6, IL-8 and 
IL-1β expression compared to monocytes (72).  These PRRs represent a target for infectious 
agents to elude the immune system. Likewise, this immune subversion can lead to increased 
susceptibility to secondary infection as other pathogens can go undetected since the innate 
abilities of the MΦ to recognize PAMPs is impaired. For instance, many Flaviviradae 
subspecies interact with these TLRs and signaling pathways such as hepatitis C virus 
	   4	  
disruption of TLR3, IRF-3, and RIG-I signaling (101), yellow fever virus attenuation of 
TLR7 and TLR9 (131), and classical swine fever virus disruption of TLR7 activity (52). 
 MΦ are an important cell for antigen uptake and presentation.  As such, MΦ 
are considered an antigen-presenting cell (APC), capable of processing peptides in the 
context of MHC class II. MΦ express fragment crystallizable receptors (FcR), which are 
important in receptor-mediated phagocytosis (16, 100). MΦ express FcγR CD16, CD32 and 
CD64 (high affinity Fcγ receptor), which when antigen is bound with antibody and 
complement (immune complex) will induce phagocytosis (4). Similarily, C3b complement 
opsonized particles can be phagocytoses by MΦ through complement receptor (CR) 3 
(CD11b/CD18) (219). After internaliztion, the phagosome is acidified through action of 
vacuolar-type H+-ATPase (V-ATPase) via transport of protons into the phagosome (189).  
Fusion of the phagosome by the lysosome provides for additional hydrolytic enzymes and 
generation of a phagolysosome. As acidification, oxidation, lysis and degredation of 
phagocytized proteins occurs, small peptides are generated and may be loaded into MHC 
class II and expressed on the cell surface (171). Co-stimulatory molecules such as CD80/86, 
and CD40 are required in conjunction with MHC class II expression to potentiate CD4+ T 
cell receptor activation. Cytosolic infection of pathogens will activate the MHC class I 
pathway, which cytosolic peptides are processed through the immunoproteosome and be 
loaded into the MHC class I molecules located in the endoplasmic reticulum (ER) (30).  
Peptide loaded MHC class I will be trafficked from the ER to the cell surface where it will 
present antigen to CD8+ T cell receptor. 
 Alveolar macrophages (AMΦs) are a tissue-derived macrophage resident to the 
surfactant layer of the alveolar spaces of the lung.  These cells are a primary innate immune 
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cell in the lung, and are one of the first cells to contact inhaled pathogens, antigens and toxins 
(49).  AMΦ are responsible for pathogen clearance, antigen presentation and cytokine 
production (50). In response to pathogens, AMΦ can secrete inflammatory mediators such as 
IL-1α, IL-1β, TNFα, IFNα/β and IL-6 (11).  AMΦ can produce granulocyte chemotactic 
factors such as IL-8, MIP-1 and leukotriene B4 which will recruit neutrophils to the lung (48, 
50, 133, 158). However, lung inflammation is tightly regulated and AMΦ are limiting in their 
pro-inflammatory response as inflammation will restrict air exchange, induce 
bronchoconstriction or tightening of the smooth muscle airway lining and narrowing of the 
lumen of the bronchi (35).  AMΦ may engulf infiltrating neutrophils to quell inflammation 
preventing the release of neutrophilic inflammatory mediators and granules (73).   Likewise 
these AMΦ will secrete IL-10 and TGF-β to induce tissue regeneration and promote an anti-
inflammatory response (35). 
 AMΦ play a vital role in pathogen clearance through abilities to phagocytize, process 
and present antigen.  The cellular membrane of AMΦ is extremely dynamic, as antigen is 
captured by non-receptor mediated endocytosis or phagocytosis through membrane ruffling. 
Within 30 minutes after internalization, the entire membrane is replaced (68). Like MDMΦ, 
AMΦ can internalize antigen through receptor-mediated phagocytosis as FcyRs, FcεRs, 
FcαRs can recognize IgG, IgE and IgA opsonized molecules respectivly (48). Similarily, 
AMΦ express CR1, CR3 and CR4 and can internalize complement opsonized microbes (64, 
74, 166). Similar to MDMΦ, after internalization of proteins or pathogens, AMΦ can process 
and present antigen in the context of MHC class II, as well as cytosolic antigen through 
MHC class I cell surface expression. 
 
	   6	  
Toll-Like Receptors 
TLRs are essential for recognition of viral and bacterial components with many 
sharing common signaling pathway components.  Within humans and cattle at least 10 TLRs 
have been determined with ligands and functions characterized.  TLRs are not equally 
expressed across each cell type, however every cell expresses a repertoire of some TLRs.  
Monocytes, MΦ and some subsets of DCs each have the capabilities of expressing all 10 
TLRs.  TLR2 interacts with TLR1 to recognize peptidoglycan and (triacyl) lipoproteins (45).  
TLR2 can also interact with TLR6 to recognize diacyl lipoproteins as well as some forms of 
lipopolysaccaride (LPS) (142, 176).  TLR3 recognizes double-stranded (ds)-RNA, as well as 
the synthetic nucleotide Poly I:C (15).  TLR4 recognizes LPS as well as some 
mycobacterium cell membrane components (176).  TLR5 recognizes flagellum (220).  TLR7 
and TLR8 recognize single-stranded (ss)-RNA (25).  TLR9 recognizes CpG unmethylated 
DNA, which is a characteristic of bacteria (209).  TLRs 2/1, 2/6, 4 and 5 are located on the 
surface plasma membrane of myeloid cells.  TLRs 3, 7, 8, 9 are located within endosomal 
compartments or within the interior of the cell.  After initial recognition by the TLRs, shared 
adapter proteins are required for propagation of signal.  Signaling molecules myeloid 
differentiation primary response gene 88 (MyD88) and TIR-domain-containing adapter-
inducing interferon-β (TRIF) are the two known adapter molecules for TLR signaling which 
leads to a classification of MyD88-dependant or MyD88-independent (TRIF) associated 
signaling (175). These adapter proteins may be a beneficial target for pathogens to evade the 
innate immune response. Recently, it has been shown that vaccinia virus, human 
immunodeficiency virus and hepatitis B virus each target MyD88 or the MyD88 complex 
leading to disruption of innate signaling pathways potentially by ubiquination and 
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degradation of the MyD88 complex or disruption of interaction with TRAM and IRAK 
molecules (130, 181, 187, 198). 
Cytokines 
 Cytokines are a class of molecules important in the initiation, regulation and control 
of the immune response.  These molecules include the interleukin (IL) and interferon (IFN) 
families as well as some chemokines.  Monocytes and MΦ induce a class of cytokines 
considered innate in their immune function.  These cytokines include IL-1β, IL-15, IL-18, 
IFNα/β and TNFα (122).  Cytokines such as IFNγ and IL-12 promote a cell mediated or T 
helper 1 response (Th1) (69).  Cytokines IL-4, IL-5, IL-10, IL-13 promote a humoral or T 
helper 2 (Th2) response (113, 124). 
 The IL-1 family of cytokines includes IL-1, IL-18 and IL-33 (5).  Unique to this 
family is the necessity of post-translational modifications required for mature protein 
production.  A multi-protein complex or inflammasome is generated in conjunction with 
NOD-like receptor family, pyrin domain containing 3 (NLRP3), apoptosis-associated speck-
like protein containing a CARD (ASC) and activity of caspase-1 (previously referred to 
interleukin-cleavage enzyme or ICE) to cleave immature IL-1 family members (pro-form) to 
an active form (90).  This processing is required for the secretion of the IL-1 family members 
(132). Similar to TLR signaling, IL-1 and IL-18 receptor signaling is mediated through 
MyD88 (5, 184, 188). 
 TNFα is produced at nearly undetectable levels in quiescent MΦ, however after 
stimuli is an immediate early-transcribed cytokine.  TNFα transcription increases sharply 
within 15-60 minutes after TLR stimulation, however TNFα mRNA is regulated post-
transcriptionally (115). The 3’ region of TNFα contains multiple AU sequences, which in the 
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context of RNA-binding proteins help to stablilze translation or silence the gene.  Similarily, 
extracellular levels of corticosteriods, prostanoids and anti-inflammatory cytokines 
downregulate TNFα expression and promote post-translational silencing (125).  
 IL-6 is a pleiotropic cytokine, which can exert T cell growth and differentiation, 
monocyte differentiation into macrophage, induce acute phase protein synthesis in the liver 
as well as development and differentiation of neuronal, osteoclast and hematopoietic cells. 
IL-6 is produced by TLR, IL-1R, and TNFR ligands in MΦ, and transcription factors NFκB, 
AP-1 and IRF induce transcription.  Translational modifications in which histone deacetylase 
(HDAC) binds to the IL-6 promotor region will induce translation of IL-6.  HDAC blocks 
histone protein H4 hyperacetylation which would turn off transcription and is a regulator of 
IL-6 transcription (115, 127). IL-6 has been shown to reduce viral replication by an early 
activation of STAT1 and STAT3 which induces IRF1/3/9 nuclear translocation and type I 
interferon production (141). 
MyD88 Dependent Signaling 
 TLRs 2/1, 2/6, 4, 5, 7, 8, 9 are considered MyD88-dependent TLRs. Of note, TLR4 
can be signal through either MyD88-dependent or MyD88-independent mechanisms. MyD88 
signaling after initial TLR dimeriztion or recognition of PAMP will eventually lead to the 
activation of NF-κB, p38 MAPK or c-jun n-terminal kinase (JNK) (145).  However, initially 
IL-1R-associated kinase (IRAK) are recruited immediately downstream of MyD88 (29).  
IRAK4 is the MyD88-peroximal kinase, which in turn recruits IRAK1. As a negative 
regulator of signaling, IRAK-M (105) appears to play an inhibitory role in activation as it 
dissociates IRAK1 and IRAK4 from MyD88 .  Downstream of IRAK1 is tumor necrosis-
factor (TNF)-receptor-associated factor 6 (TRAF6) (103), which can activate upstream 
	   9	  
kinases for p38 and JNK activation as well as initial degradation of inhibitor of NFκB kinase 
(IκB) complex. TRAF6 through the recruitment of transforming-growth-factor-β-activated-
kinase 1 (TAK1) and TAK1-binding protein 2 (TAB2), the ubiquitin-conjugating enzyme E2 
variant 1 (UEV1A) and ubiquitin-conjugating enzyme 13 (UBC13) becomes an activating 
complex by which contributes to the recruitment of the IKK complex, subsequent 
phosphorylation of the IKKαβ subunits by NFκB essential modulator (NEMO or IKKγ) 
which tags the IκB for ubiquitination and proteosomal degradation (208).  Similarly the 
TRAF6/TAK1 complex can activate and recruit dual-specificity mitogen-activated protein 
kinase kinase (MKK) MKK3/MKK6 for p38 MAPK phosphorylation as well as MKK7 for 
JNK phosphorylation (41). Translocation of NFκB, p38 or JNK can lead to transcription of 
pro-inflammatory cytokines and mediators (145). 
MyD88-Independent Signaling 
 MyD88-independent pathways are mediated by TIR-domain-containing adapter-
inducing interferon-β (TRIF).  Only TLR3 and TLR4 are known to signal through TRIF (19, 
32). Although, MyD88-independent, TRIF signaling does include some shared signaling 
molecules. For instance, TRIF can interact indirectly or directly with TRAF6 to initiate IKK 
signaling and downstream NFκB activation and subsequent pro0inflammatory cytokine 
transcription (104). However, TRIF can interact with TRAF3 and NAK-associated protein 1 
(NAP1) to induce interferon regulatory factor (IRF)3 or IRF7activation which in turn induces 
type-I interferon transcription (143).  However, TRIF signaling can induce apoptosis by 
which receptor-interacting protein 1(RIP1) activates pathways involving FAS-associated 
death domain (FADD) and subsequent apoptotic cascades (96).  
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c-Jun N-Terminal Kinase (JNK) 
 JNK is a member of the stress-activated protein kinase (SAPK) group of mitogen-
activated protein kinases (MAPKs).  Additionally included in the SAPK MAPKs are p38 
MAPK families comprised of p38α, p38β, p38γ and p38δ (199).  JNK includes three family 
members, JNK1, JNK2 and JNK3 that are differentially expressed depending on cell or tissue 
type (62, 134, 201, 205).  JNK3 is primarily expressed in brain, heart, and testis; whereas 
JNK1/2 are widely and constitutively expressed among myeloid, lymphocyte and epithelial 
cells (165).  Of note, JNK1/2 expression barely detectably in naïve T and B cells although 
will be induced after antigen stimulation (62).  Four isoforms of JNK1 (JNK1α1, JNK1β2, 
JNK2α2, JNK1β2) and JNK2 (JNK2α1, JNK2β2, JNK2α2, JNK2β2) have been described 
dependent on tissue type; however functional characteristics of these isoforms have yet to be 
completely elucidated (21, 165). 
 In myeloid cells, JNK activation occurs by phosphorylation after an upstream multi-
component cascade of kinase phosphorylation. TLR or IL-1R signaling triggers induction of 
this cascade (93). After receptor stimulation, a class of kinases, MAP3K (mitogen-activating 
kinase kinase kinase) will become phosphorylated and initiate phosphorylation of MAP2Ks, 
which in turn will phosphorylate MAPKs.  21 MAP3Ks have been identified with many of 
them having overlapping ability to provoke MAPK stimulation (165).  The large number of 
MAP3Ks may suggest multiple MAP3K are required for activation of MAPK.  Analyses of 
gene knockout studies have demonstrated JNK phosphorylation is greatly affected in cells 
lines lacking TPL-2, ASK1, TAK1, MLK3, MEKK1 or MEKK3 (205). JNKK1 (MAP2K4) 
and JNKK2 (MAP2K7) will phosphorylate and activate JNK at amino acid residues Thr183 
and Tyr185 (89). Recently, JNK scaffolding proteins have become more characterized as these 
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proteins are essential in coordinating the formation of JNK signaling complexes (47, 210).  
Phosphorylation of JNK will allow it to translocate the nucleus to activate transcription 
factors c-Jun, ATF2, ELK1, SMAD4, p53 and HSF1 (144). Although some of the 
transcription factors activated by JNK can induce an inflammatory cytokine response, other 
are important for cell cycle regulation and initiation of apoptosis (71, 127, 217). 
Transcription Factor Family NF-κΒ Activation 
 NF-κB is a family of transcription factors that arbitrates a multitude of cellular 
processes; however it plays an important role in the regulation of immune responses. In 
mammals, five members of the NF-κB family exist: RelA (p65), RelB, c-Rel, NF-κB1 (p105) 
and NF-κB2 (p100) (173). As overexpression of NF-κB can lead to inflammatory disorders, 
regulation is tightly controlled (98).  Under inactive conditions, NF-κB dimerizes and is 
bound to inhibitory IκB proteins, which are localized in the cytoplasm (167).  Under signal 
activation conditions, such as downstream of TLR or IL-1R activation, the IκB kinase (IKK) 
complex subunits IKKα/β become phosphorylated through the regulatory subunit IKKγ 
(NEMO) (179). These IKK catalytic subunits initiate the phosphorylation IκB, which is 
targeted for ubiquitination and degradation that releases NF-κB dimers to translocate to the 
nucleus and transcriptional regulation of genes can occur (146, 179).  Generally NF-κB 
pathways are categorized into two groups, canonical and noncanonical. Canonical pathways 
are dependent on IKKβ and NEMO, which lead to phosphorylation of p65 containing NF-κB 
dimers (14). Noncanonical pathways depend on IKKα-mediated phosphorylation of the p100 
associated with RelB, leading to creation of p52-RelB complexes (8, 14, 179). Activation of 
NF-κB can result in pro-imflammatory cytokine release, as regulation of IL-1α, IL-1β, IL-2, 
	   12	  
IL-6, IL-8, IL-10, IL-12, IL-13, IL-23 and IFNβ are controlled, in part, by NF-κB (31, 83-85, 
99, 111, 117, 126,180). 
 
Bovine Viral Diarrhea Virus (BVDV) 
Bovine viral diarrhea virus (BVDV) is an enveloped single-stranded positive-sense RNA 
virus and is the etiological agent of bovine viral diarrhea (BVD). Disease associated with 
BVDV is multifaceted with animals suffering from severe acute, subclinical, or mucosal 
disease.  Similarly, an immune tolerant persistently infected (PI) animal displaying no 
clinical symptoms is possible and these PI animals shed high amount of virus.  Within the 
cattle industry, BVDV can be devastating leading to millions of dollars in loss either through 
BVD or secondary infection caused by increased susceptibility to disease (163). 
Unsolved Questions 
 BVDV vaccines are widely available (54).  However genetic variation within the 
subgenotypes of BVDV strains make is difficult to induce wide protection against various 
field strains (161).  However, many feedlot managers do not vaccinate due to cost, lack of 
information on vaccines, or a generalized fear that vaccination may contribute to a severe 
condition deemed mucosal disease (33, 110, 139). As such, a primary focus of BVDV 
research has been on vaccination strategies.  A few studies have suggested that BVDV 
induces an immunosuppressive host with modulation in T cell repertoire and response to 
secondary infection. For example, in vivo BVDV infection of calves induce a shift the 
immune response toward the T-helper 2 (Th2) response and avoid the production of cell-
mediated immunity or T-helper 1 response (Th1) (36).  Furthermore, the proliferative 
response of either allotypic or memory CD4+ T cells are greatly reduced when mixed with in 
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vitro infected monocytes (65). Similarly it has been suggested that lymphoid cytokine 
secretions (65) and disruption in chemotaxis (27) may be some contributing factors of 
immune suppression. The ability of APCs such as monocytes and MΦ to potentiate T cell 
responses either in response to APC generated cytokines or cell surface marker expression is 
unknown in response to BVDV-2 infection.  As such, the underlying mechanisms of 
immunomodulation after BVDV-2 infection are unknown.   
Economic Impact 
 The yearly economic impact of BVDV is estimated to be in the millions of dollars in 
the United States.  Reproductive costs are estimated at $376,000,000 to $1,500,000,000 per 
year, as these costs are associated with rebreeding animals due to abortion, stillbirths, or 
underweight calves (88, 160). Costs to milk production are estimated to be between 
$330,000,000 to $494,000,000, which is associated with decreased milk production from 
acute disease or underperforming PI cattle (88, 160). Feedlot sales associated with acute 
infection, exposure to PI animals, increased secondary infections, and production losses 
associated with diversion of resources to manage infected cattle lead to an estimated 
$360,000,000 in losses (88, 160). These yearly costs only refer to low virulence BVDV 
strains as losses due to high virulence strains may reach an estimated  $100,000 per herd 
(120).  Globally, BVDV monetary costs are within the equivalent of billions in US dollars 
(76, 79-81, 123, 157, 159, 183, 185, 191). 
Genome and Strains 
BVDV is in the Pestivirus genus, which includes classical swine fever virus (CSFV) and 
border disease virus (BDV).  BVDV is also a member of the Flaviviradae family, and is 
closely related to hepatitis C virus (HCV).  This close similarity to HCV has allowed for the 
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development of BVDV as a surrogate model of HCV (28).  Members of Flaviviradae also 
include dengue virus (DV), West Nile virus (WNV), yellow fever virus (YFV) and St. Louis 
encephalitis virus (SLEV).  The genome of BVDV, HCV and other viral family members are 
approximately 12.5kb in length.  The BVDV genome is organized into 12 genes flanked by a 
5’ nontranslated region (NTR) and a 3’ non-polyadenylated NTR. Within the 5’ 
nontranslated region is an internal ribosome entry site (IRES).  This site drives cap-
independent translation of the viral open reading frame, generating one single large 
polyprotein.  This polyprotein is processed by a combination of viral and host proteases to 
produce the mature viral proteins.  N-terminal protease (Npro) is the first gene transcribed off 
of the genome, which is a nonstructural gene and encodes an autoproteolytic subunit able to 
cleave its own C terminus (116, 168).  The following genes are the structural genes of capsid 
(C), virion associated envelop glycoproteins (Erns, E1, E2) and P7, a small hydrophobic 
protein. The next six genes (NS2, NS3, NS4A, NS4B, NS5A, NS5B) comprise the majority 
of the BVDV genome and are nonstructural (NS) genes. This is a common feature of the NS 
genes throughout the Flaviviridae family and make up the amino terminal region of the 
genome (153). Interestingly, the BVDV genome can differ depending on the 
cytopathogenicity of the virus (23, 138).  Cytopathogenicity is associated with the cleavage 
of the NS2/3 protein into the NS2 and NS3 proteins, whereas noncytopathic (ncp)-BVDV 
strains only express one whole protein referred to as NS2/3 and therefore ncp-BVDV contain 
only 11 functional genes (109, 138, 155, 196). This classification system of BVDV as 
cytopathic and non-cytopathic (cp/ncp) is determined by viral effect in epithelial cell culture.  
Biotypes of BVDV include types 1 and 2 which are determined by genetic variation and 
sequence identity (75). BVDV-2 genotypes can be further characterized as atypical or high 
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virulence (HV) and typical or low virulence (LV) as determined by viral titres in vivo and 
correlate to severity of acute disease (119, 120).  In the United States biotypes of BVDV-1 
and BVDV-2 are common (195). Recently, a newly characterized virus, the Hobi-like viruses 
have been isolated in South America and the Far East (169).  The Hobi-like viruses are 
genetically and antigenically similar to BVDV 1 and 2, which may potentially classify these 
viruses as a BVDV genotype (10, 97, 182). 
Vaccines 
 Within the United States, most BVDV vaccines consist of either a modified live viral 
vaccines (MLV) or heat killed vaccines to induce protective antibodies in the host (56).  
MLV BVDV vaccination is generally the preferred method of vaccination as the MLV 
vaccines induce broad protection to varying biotypes of BVDV and may provide protective 
immunity as early as 3 days post-vaccination (57, 58). MLV vaccination programs require 
one booster vaccination and yearly revaccination (55).  As with most veterinary vaccination 
programs, BVDV is usually included as part of a multivalent vaccine against respiratory 
pathogens: bovine respiratory syncytial virus (bRSV), bovine herpesvirus-1 (infectious 
bovine rhinotracheitis or infectious pustular vulvovaginitis) (bHV-1.1, bHV1.2), bovine 
parainfluenza-3 virus (bPI-3) and bacterial pathogen Mannheimia haemolytica (57-61).  
However, vaccination of pregnant cows with MLV may induce infection and disease of the 
fetus (51, 118, 147, 213).  Likewise vaccination is not always protective, cannot be used to 
treat persistently infected cattle and can potentially contribute to mucosal disease (22, 194). 
Mode of Transmission 
 Transmission occurs via ingestion, inhalation and fomites (non-living sources such as 
boots and vehicles). Transmission may occur horizontally from cattle or through other 
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animals such as deer, alpacas, llamas and camels, which are host to BVDV (12, 34, 77, 128, 
156, 215).  Vertical transmission may also occur within an infected dam to fetus generating a 
persistently infected (PI) calf (7).  PI animals display no clinical symptoms of disease, 
however are immune suppressed and shed high amount of virus (161). Superinfection of PI 
animals with cytopathic BVDV, may lead to a fatal syndrome called mucosal disease (23).   
Acute disease of non-PI animals may range from severe sickness, with bloody diarrhea, high 
fever, mouth ulcers, and pneumonia to mild sub-clinical acute; however disease does lead to 
an immune suppressed host (119-121).   The majority of BVDV infections are believed to be 
transmitted via a PI animal, as these animals are non-symptomatic and difficult to clinically 
detect (151). Virus from PI animals is shed in all body secretions including nasal discharge, 
saliva, tears, milk, feces, urine and semen. 
Interaction of BVDV Proteins with Immune-associated Cellular Molecules 
There is little known about BVDV in context of either immune cell associated 
pathology or mechanisms of lasting immunological suppression. The N-terminal region of 
Npro of BVDV has been associated in vitro with the ubiquitination and subsequent 
proteosomal degradation of interferon regulatory factor-3 (IRF-3) (82, 140, 202).  Likewise 
the Erns protein has been shown to also disrupt the IRF-3 signalling pathways by interacting 
directly with double stranded (ds)RNA and subsequently blocking recognition of the 3’-
phosphates by retinoic acid-inducible gene-I (RIG-I) and induction of the type-2 interferons 
(IFNα/β) (92).  Erns is also unique as it has been shown to be present in high concentrations 
within infected cells, secreted, and subsequently found extracellularly (203) which may 
potentially effect non-infected cells. The NS2 protein has been suggested to have similar 
function as HCV as an inhibitor of IFN-β (102, 178), although more recent studies have 
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indicated importance in virion morphology (114), and in coordination with expression of 
NS3/4A as an important mediator in induction of apoptosis (172).  NS5A is one of the least 
characterized genes of BVDV, however there is evidence of alteration of NFκB transcription 
factor activation via blockade of phosphorylation of IKK-β.  This disruption in activation is 
attainted by interfering with the interaction of the IKK complex with NFκB-inducing-kinase 
(NIK) complex (216).  This data fits with the observation from another study by which 
transcriptional dysregulation of the NFκB pathway is induced in BVDV infected cells (214). 
Cellular Entry and Tropisms 
 BVDV is believed to enter cells through receptor-mediated internalization by CD46 
(106, 136, 192), a co-receptor for the regulation of activation of the complement cascade.  
CD46 is expressed on all nucleated cells, which associates with the multitude of tissues and 
cell types in which BVDV has been isolated (17, 18, 65, 66, 119-121, 129, 149, 162).  After 
initial attachment, BVDV is internalized via clatherin-mediated endocytosis (70).  However, 
BVDV does not traffick to the endosome (108, 135), indicating that some modification of 
cellular compartmentalization may occur after internalization.  Interestingly, cells resistant to 
infection with BVDV (CRIB) (53) have been generated in vitro, although expression of 
CD46 is present.  Previous studies have believed the importance of low density lipoprotein 
(LDL) receptor as important in internalization of BVDV (2), as CRIB cells are deficient in 
expression of LDL receptors; however recent studies have suggested LDL receptor is not 
important for viral entry (107).  As such, CD46 is believed to be important for viral entry, 
however the possibility persists that other cellular surface molecules may be important as co-
receptors for viral entry.  Likewise, the use of multiple receptors is important for HCV 
internalization (108, 193) and may be a commonality to BVDV and other Flaviviradae. 
	   18	  
Impact on Circulating Lymphocytes 
There is evidence of lymphopenia in sub-clinically acute and severe acute infected 
animals (119).  Initially, both CD4+ and CD8+ T cells are depleted in the periphery with B 
cells and γδ-T cells maintaining circulation slightly longer (26, 149, 152, 164).  This decrease 
in circulating lymphocytes has been hypothesized to be immune cell induced apoptosis 
although viral mediated necrosis may be occurring (36). Monocytes have been suggested as 
mediators of peripheral lymphopenia, as T cells initiate apoptosis when co-cultured with 
BVDV-infected monocytes (112). However evidence of potential tissue infiltration and 
subsequent immune mediated lesion development may be another explanation (17) for the 
decrease in circulating lymphocytes.  Peripheral monocytes are not decreased in numbers and 
are potentially resistant to cytopenia induced by BVDV infection (119-121).  
Impact on Monocytes 
Monocytes have been identified in vitro and in vivo as supportive to BVDV 
replication (3, 18, 87, 129).  With resilience to BVDV induced cytopenic effect (148) but not 
viral replication (65), monocytes potentially can be impaired in function by BVDV not 
induced by apoptosis or necrosis (3, 154).  
An early study examined the effects of BVDV-1 on monocytes infected in vitro in 
which no differences were seen between the intensities of the hybridization signals of IL-1 
obtained using RNA extracted from LPS-stimulated BVDV-infected and uninfected 
monocytes. However there was a demonstration of inhibition of IL-1 activity in monocyte 
supernatants as supported by significant suppression of mouse thymocyte proliferation when 
compared to uninfected control supernatants (95).  More recently, it has been shown in vitro 
that BVDV-1 infection of monocytes resulted in reduced IL-1β and IL-6 mRNA transcription 
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and decreased IL-1β, IL-6 and TNFα secretion compared to uninfected controls (115).  As 
there are few studies on the effects of BVDV on monocytes it is important to consider 
modifications of monocyte cytokine secretion induced by other Flaviviridae. Peripheral 
blood monocytes isolated from individuals chronically infected with HCV and stimulated 
with LPS exhibited enhanced expression of TNFα, IL-1β and IL-6 protein compared to 
aviremic or uninfected individuals (46, 211). Moreover, human monocytes infected with 
Dengue virus and stimulated with LPS were found to secrete high levels of IL-1β, TNFα, 
IFNα, IL-6, IL8, IL-12, MIP-1α and RANTES compared to uninfected control cells (24, 37).  
Hypersensitivity of PRRs and enhanced expression of proinflammatory cytokines are 
contributing factors to severe clinical disease and a prolonged period of recovery (38, 190, 
197, 200).  Noteworthy is that in highly virulent infections of BVDV-2, recovery is 
prolonged compared to the typical or low virulent infections (119).  Enhanced pro-
inflammatory cytokine secretion from monocytes has been seen in cases of viral infection 
with associated peripheral lymphocyte depletion or increased induction of leukocyte 
apoptosis (67, 78, 170).  
Impact on Monocyte Derived Macrophages 
 Few studies to date have examined the impacts of BVDV infection on the function of 
monocyte derived macrophages.  Bone marrow derived macrophages (BMMΦ) infected with 
BVDV-1 in vitro have been shown to secrete less TNFα protein in response to LPS or 
bacterial infection compared to uninfected BMMΦs (1).  As with other Flaviviradae TLR 
hyporesponsiveness has been demonstrated in MDMΦ from chronically infected HCV 
patients, which correlated to more severe disease and worse clinical outcome (40, 125).  
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Yellow fever virus and St. Louis encephalitis virus infection reduced IL-1β levels in LPS-
stimulated MDMΦ compared to uninfected control cells (9).  
Impact on Alveolar Macrophages 
 AMΦ are a terminally differentiated tissue macrophage resident to the alveolar spaces 
of the lung, which further play roles in lung homeostasis as well as tissue remodeling 
following lung damage (35).  These cells respond to pathogens through production of 
proinflammatory cytokines (44) and are of interest to BVDV infection in the lung as these 
cells will be one of the first innate immune cells to encounter the virus.   One study has 
shown that in vivo BVDV-1 infection with in vitro restimulation with BVDV-1 of AMΦ 
greatly reduced normal function of these cells, with a decline in their ability to secrete 
neutrophil chemotactic factors, a downregulation of Fcγ receptor and CR3 expression, and a 
reduction in phagocytic capability (206).  
 
Specific Aims 
 Disease associated with BVDV infection can be devastating ranging to millions of 
dollars in loss to the cattle industry.  As well, infection with BVDV leads to an immune-
suppressed host though an unknown mechanism(s).  Although there are vaccines available, 
they are not broadly protective and ineffective in PI cattle. The myeloid lineage cells such as 
monocytes and MΦ are important in recognizing BVDV as well as initiating an adaptive 
immune response.  There is little information on the effects of BVDV in vivo on the 
functionality of these cells and a better understanding can lead to potential treatment.  
Investigating the effects on cytokine production, expression and response of TLRs and 
functional aspects of phagocytosis are critical.  The specific aims in these studies utilize 
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neonatal calves for in vivo study and 1-year-old cattle for cell donors during in vitro 
investigation. BVDV-2 strain 1373 was utilized as it is a field strain, which induces severe 
acute disease and is a highly virulent. BVDV-2 strains RS886 and 28508 are subclinical 
acute disease inducing strains, which are lower in virulence and typical of field isolates from 
PI cattle or subclinical infections. BVDV-2 strain 296c is a cytopathic strain whereas BVDV-
2 strain 296nc is an isogenic non-cytopathic strain.  These isogenic strains were chosen as the 
only differences between the strains are the NS2/3 coding regions.  BVDV-2 strains 1373 
and RS886 were utilized for in vivo experimentation whereas BVDV-2 strains 1373, 28508, 
296c and 296nc were used for in vitro experiments. Both in vivo and in vitro models were 
used to characterize viral effects on cytokine expression and secretion, TLR responsiveness, 
signaling events, and phagocytosis of myeloid cells after exposure to virus. 
Specific Aim 1. Determine the effects of BVDV-2 virulence on cytokine expression of 
myeloid lineage cells isolated from high or low virulence BVDV-2 infected neonatal calves 
compared to cells from uninfected calves. 
S.A.1 Hypothesis. Each of the myeloid lineage cell types isolated from BVDV-2 infected 
calves will exhibit a decrease in proinflammatory cytokine expression, especially in the 
calves infected with the highly virulent 1373 BVDV-2 strain, compared to cells isolated from 
uninfected calves. 
 There is limited information on the cytokine responses from myeloid lineage cells 
isolated from an in vivo infection with BVDV and none on BVDV-2 biotypes of varying 
virulence.  Likewise, there are no studies comparing mRNA and protein from three different 
myeloid lineage cell types during an in vivo BVDV infection and none investigating the 
mechanisms of viral modulation of cell signaling molecules related to TLRs. Monocytes and 
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alveolar macrophages were isolated by plastic adherence and used for ex vivo analysis. Data 
collected from the proposed studies of this aim determine the functions of these cells were 
modulated by BVDV-2 infection. The following studies were utilized to elucidate the effects 
of BVDV on myeloid lineage cells isolated from infected neonatal calves: 
1. Cytokines were quantified for mRNA expression by qPCR utilizing SYBR Green 
chemistry and bovine specific primers 
2. Identified cytokine protein secretion by utilizing ELISA based assays. 
3. Determined the viral effects on intracellular signaling molecules by western blot.  
4. Identified a potential interaction between BVDV and host proteins by protein 
complex immunoprecipitation (Co-IP). 
Specific Aim 2. Determine the effects of an in vitro infection of varying biotypes of BVDV-
2 strains on MDMΦ and TLR responsiveness. 
S.A.2 Hypothesis. The highly virulent and cytopathic strains of BVDV-2 will induce greater 
amounts of pro-inflammatory cytokines in myeloid lineage cells than the low virulence and 
non-cytopathic isogenic strains, but will induce a TLR hypo-responsiveness similar to that 
observed in in vivo MDMΦ from S.A.1. 
 There have been no in vitro studies comparing isogenic strains of cytopathic and 
noncytopathic BVDV-2 or strains of varying virulence on the effects of MDMΦ. Healthy 
BVDV-free cattle were used as blood donors and MDMΦ were generated from blood 
monocytes. TLR agonists were used in MDMΦ incubated for 48 h after viral inoculation. 
Data collected from the following studies determined the effects of BVDV-2 on the cytokine 
responses of MDMΦ prior to and after TLR ligation. The following studies were used to 
elucidate the effect of BVDV-2 on the MDMΦ: 
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1. Cytokines were quantified for mRNA expression by qPCR utilizing SYBR Green 
chemistry and bovine specific primers. 
2. Identified cytokine protein secretion by utilizing ELISA based assays. 
3. Determined the viral effects on intracellular signaling molecules by western blot.  
Specific Aim 3. Determine the effects of BVDV-2 infection of varying virulence biotypes on 
MDMΦ antigen processing, presentation, phagocytosis and phagosome acidifcation and 
oxidative capacity. 
S.A.3 Hypothesis. The high virulence and cytopathic BVDV-2 infected MDMΦ will 
decrease expression of cell surface markers associated with antigen presentation as well as 
decreasing the phagocytic capabilities and acidification of the phagosome compared to low 
virulence and isogenic non-cytopathic infected cells. 
 There have been no in vivo or in vitro studies to compare varying strains of BVDV-2 
biotype effects on MDMΦ antigen presentation and phagosome functionality. For in vivo 
analysis, BVDV-2 strains 1373 or RS886 were used to inoculate neonatal calves and 
peripheral blood CD14+ cells were isolated.  For in vitro experimentation healthy BVDV-
free cattle were used as blood donors and MDMΦ were generated from blood monocytes. 
MDMΦ incubated for 48 h after viral inoculation prior to phagocytosis assay. Data collected 
from the following studies determined the effects of BVDV-2 on the expression of cell 
surface markers and phagosome processing. The following studies were used to elucidate the 
effect of BVDV-2 on the MDMΦ: 
1. RNAseq analysis will be used to determine the transcriptome of the in vivo 
infected calves. 
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2. Cell surface markers from MDMΦ infected in vitro were quantified for mRNA 
expression by qPCR utilizing SYBR Green chemistry and bovine specific primers. 
3. Flow cytometry will be used to analyze surface antigen expression. 
4. Assess phagosome acidification and oxidative capacity by bead-based flow 
cytometry assay. 
5. Determine phagocytic capability by bead-based flow-cytometric assay. 
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Figure 1. Schematic diagram of Toll-like receptor pathways.  TLRs 2/1, 2/6, 4, 5, and 7/8 
signal through MyD88 dependent pathway. TLRs 2/1, 2/6 recognize bacterial cell membrane 
glycoproteins.  TLR4 recognizes lipopolysaccaride with CD14 and MD-2. TLR 7/8 are 
located in the endosomal compartment and recognize single stranded viral RNA.  This 
pathways leads to activation of NFκB family members, JNK and p38, which activate 
transcription of pro-inflammatory cytokines.  TLRs 3 and 4 can signal though MyD88-
independent pathways involving TRIF. TLR3 is located in the endosomal compartment and 
can recognize double stranded viral RNA.  This can lead to activation of NFκB family 
members, JNK, p38, IRF and apoptosis. 
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Figure 2. Schematic diagram of Bovine Viral Diarrhea Virus (BVDV) genome. The BVDV 
genome is initially generated as one large polyprotein.  For functional proteins to be 
generated, host peptidases, golgi proteases and the viral NS3 protease will cleave the 
polyprotein. The 5’ NTR of the BVDV genome is highly conserved followed by the 
nucleocapsid, capsid, and envelope proteins. The p7 is a small hydrophobic protein of 
unknown function, with the NS2-3 peptide a protease that cleaves NS4 and NS5. The 
envelope E1 and E2 proteins are antigenic; and antibodies against these proteins are 
protective. 
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CHAPTER TWO. BOVINE VIRAL DIARRHEA VIRUS GENOTYPE 2 
IN VIVO INFECTION MODULATES TLR4 RESPONSIVENESS IN 
MYELOID CELLS VIA A DECREASE IN MYD88 EXPRESSION AND 
IKKΒ PHOSPHORYLATION 
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ABSTRACT 
Bovine viral diarrhea virus (BVDV) causes clinical signs in cattle ranging from mild 
to severe acute infection which can lead to increased susceptibility to secondary bacteria.  In 
this study we examined the effects of BVDV genotype 2 (BVDV-2) infection on the  ability 
of myeloid lineage cells derived from infected calves to produce proinflammatory cytokine 
mRNA and protein with or without bacterial LPS stimulation. Monocytes, monocyte-derived 
macrophages (MDMΦ), and alveolar macrophages (AMΦ), were chosen to represent 
differing stages of myeloid differentiation. It was found that monocytes isolated from 
infected calves produced higher levels of proinflammatory cytokine mRNA compared to 
uninfected calves and were hyperresponsive to LPS based on an increase in proinflammatory 
cytokine transcription and secretion. In contrast, MDMΦ inflammatory cytokine gene 
expression and secretion were, in general, significantly reduced compared to cells isolated 	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from control calves. There was a discordance between AMΦ cytokine gene expression and 
protein secretion, in that while mRNA levels were significantly reduced, protein secretion 
was similar to that of stimulated cells from control animals. The differential cytokine 
expression of these macrophage cells was attributed to the modulated expression of myeloid 
differentiation primary response gene 88 (MyD88) protein and phosphorylated inhibitor of 
nuclear factor kappa-B kinase subunit beta (IKKβ).  Thus, BVDV-2 infection results in the 
modulation of LPS-induced myeloid pro-inflammatory cytokine expression by effects on two 
separate components of TLR4 signaling cascades involving MyD88 and transcription factor 
NFkB activation. 
 
INTRODUCTION 
Bovine viral diarrhea viruses (BVDV) are enveloped single-stranded positive-sense 
RNA viruses comprised of two species, BVDV-1 and BVDV-2, in the Flaviviridae family 
(19, 56). The BVDV genome is approximately 12.5kb in length and is organized into 12 
genes flanked by a 5’ nontranslated region (NTR) and a 3’ non-polyadenylated NTR.  The 
BVDV genome encodes a large polyprotein which is cleaved into varying polypeptides. Six 
genes (NS2, NS3, NS4A, NS4B, NS5A, NS5B), which comprise the majority of the BVDV 
genome, are nonstructural (NS) genes, which is a common feature throughout the 
Flaviviridae family and make up the amino terminal region of the genome (57). 
Classification of BVDV as cytopathic (cp) or noncytopathic (ncp) biotypes is based on their 
cytopathogenicity in epithelial cell culture (55). Cytopathogenicity is associated with the 
cleavage of the NS2/3 protein into the NS2 and NS3 proteins, whereas ncp-BVDV strains 
only express one whole protein referred to as NS2/3 and therefore ncp-BVDV contains only 
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11 functional genes. NS5A is one of the least characterized genes of BVDV; however there is 
evidence of NS5A involvement in the alteration of the NFκB activation by blocking 
phosphorylation of the inhibitor of κB kinase binding protein-β (IKKβ) in vitro (82). BVDV-
2 genotypes can be further characterized as atypical or high virulence (HV) and typical or 
low virulence (LV) as determined by viral titres in vivo and correlate to severity of acute 
disease (55). 
Acute BVDV infections result in varying clinical syndromes in cattle ranging from 
subclinical to an acute, severe sickness, with bloody diarrhea, high fever, mouth ulcers, and 
pneumonia. Sub-clinically, there is evidence of lymphopenia in severely infected animals 
(39-42).   Furthermore, BVDV is believed to be a factor in potentiating bovine respiratory 
disease complex (BRDC) in transported cattle.  Susceptibility to infection with bacterial 
pathogens such as Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and 
Mycoplasma bovis is greatly increased in cattle with BRDC (14, 26).  Secondary bacterial 
infection is the leading cause of morbidity and mortality among feedlot cattle (23, 51, 69).  
Mechanisms whereby BVDV predisposes cattle to secondary bacterial infection have not 
been completely elucidated. 
In response to inflammatory signals, circulating monocytes rapidly disseminate into 
infected tissues and develop into antigen presenting cells.  Previous research supports the 
idea that monocytes may be a vehicle for dissemination of BVDV throughout the host (24, 
36).  Studies have shown that BVDV replicates in monocytes (3, 6), however unlike 
lymphocytes, a reduction in the numbers of monocytes are not sustained following acute 
infection (40-43).  While numbers of monocytes are not effected, studies have shown that in 
vitro BVDV may impair cellular functions of these cells including sugar metabolism, 
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interferon induction, apoptosis and migration (3, 52).  Similarly, in vitro ncp BVDV-1 
infection of monocytes downregulates TNFα, IL-1β and IL-6 gene expression (37). To date, 
there have been no in vivo studies of BVDV-2 impact on myeloid cell cytokine expression or 
mechanisms of immune modulation in these cells. 
Monocytes may differentiate into macrophage cells (MΦ) or dendritic cells (DCs).  
MΦ are important in recognizing innate recognition signals or pathogen associated molecular 
patters (PAMPs) to initiate an immune response (30). These receptors represent a potential 
target for infectious agents to subvert the immune system. This immune subversion can lead, 
in some cases, to increased susceptibility to secondary infection. One family of innate pattern 
recognition receptors (PRRs) are the toll-like receptors (TLRs). TLRs are essential for 
recognition of viral and bacterial PAMPS with many sharing common signaling pathway 
components (47). Following activation, TLRs associate with cytosolic receptor-proximal 
proteins containing TIR domains, including myeloid differentiation primary response gene 
88 (MyD88) or TRIF (TLR-associated activator of interferon).  MyD88 recruits IRAK-1, 
which can complex with TRAF-6, leading to activation of transcription factor NFkB family 
members necessary for expression of proinflammatory cytokine genes. In contrast, the 
MyD88-independent, TRIF pathway induces activation of TBK-1, leading to 
phosphorylation of IRF-3, and cytokine gene induction. Many Flaviviridae species modulate 
PRR signaling pathways, such as HCV disruption of TLR-3, IRF-3, and RIG-I signaling (34), 
Yellow Fever Virus (YFV) reduction of TLR7 and TLR9 signaling (46), and Classical Swine 
Fever Virus (CSFV) modulation of TLR7 activity (22). Recently, it has been shown that 
other viruses, including HCV, Vaccinia virus (VV), Human immunodeficiency virus (HIV) 
and Hepatitis B virus (HBV) specifically target the MyD88-dependant signaling pathways 
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leading to disruption of TLR signaling through electrostatic interactions between viral 
proteins and MyD88-TRAF adapter molecules or mechanisms that have yet to be elucidated 
(45, 62, 64, 71). 
The aim of this study was to examine cytokine mRNA and protein expression of 
myeloid lineage cells isolated during an in vivo BVDV-2 infection and investigate the ability 
of these cells to respond to subsequent bacterial LPS stimulation. Differential cytokine 
responses were observed for monocytes, MDMΦ and AMΦ from BVDV-2-infected calves. 
We found that the decrease in production of inflammatory cytokines in response to LPS may 
be due in part to the differencess in MyD88 expression and phosphorylation of IKKβ in 
myeloid lineage cells from BVDV-2 infected calves.  
 
MATERIALS AND METHODS 
Animals. Eighteen clinically healthy, colostrum-deprived Holstein calves were used 
in two experiments.  Calves were negative for BVDV and antibodies to BVDV as determined 
by virus isolation from buffy coat followed by polymerase chain reaction (PCR) and serum 
neutralization using BVDV 1 strain NY-1 and BVDV 2 strain 1373 (13). 
Viral inoculum. The ncp BVDV-2 strain 1373 was isolated during a clinically severe 
outbreak in Ontario, Canada in 1993. The ncp BVDV-2 strain RS886 was isolated from the 
tissues of a clinically normal, asymptomatic persistently infected calf. The viruses used for 
inoculation had been passed once in calves followed by 2 passages in tissue culture. 
Experimental procedures. Experimental infections, run in duplicate, were 
conducted under BL2 containment. Calves were group housed by experimental group. Two- 
to five- week old calves were inoculated intranasally with 5mL of 105-6 TCID50 of BVDV-2 
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strain 1373 (n=3/replicate) or RS886 (n=3/replicate). Additional calves (n=3/experiment) 
were mock inoculated and served as age-matched negative controls. Clinical signs were 
monitored twice per day. Blood samples were collected in anticoagulant tubes on days 4 and 
12 post inoculation.  Numbers of leukocytes and platelets were determined for each animal. 
Buffy coat was examined for BVDV by viral isolation and PCR for confirmation of infection. 
Animal procedures employed in these studies were approved by the National Animal Disease 
Center Institutional Animal Care and Use Committee. 
Cell Count Populations. Cells were enumerated by using a Hemavet 950 (Drew 
Scientific, Dallas TX) calibrated to bovine blood samples and counted in duplicate.  
Monocyte counts were confirmed by flow cytometry using a BD LSR flow cytometer 
(Becton Dickinson, San Jose, CA) labeled with an anti-CD14 antibody [MCA1568PB] 
(Serotec, Raleigh, NC). 
Monocyte isolation. Peripheral blood mononuclear cells were isolated and red blood 
cells (RBC) lysed with buffered ammonium chloride salt solution.  After RBC lysis, cells 
were washed with sterile phosphate-buffered saline (PBS).  Cells were resuspended in 
complete RPMI 1640 (cRPMI) containing 10% fetal bovine serum (tested free of BVDV and 
antibodies against BVDV), 2mM L-glutamine, 1% antibiotic–antimycotic solution, and 
gentamicin sulfate (Gibco, Carlsbad, CA).  Monocytes were isolated by plastic adherance.  
Ice-cold PBS was added to the plate and adherent cells were removed with a cell scraper.  
Cells were centrifuged at 1180 x g (Sorvall RC3C Plus, Thermo Scientific, Waltham, MA), 
and resuspended in cRPMI 1640 at 5x106 cells per mL.  Monocytes were plated in 96-well 
round bottom tissue culture plates in 100 µL medium. Monocytes selected for MDMΦ were 
cultured for 7 days with media change every 2-3 days prior to in vitro stimulation. 
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Monocytes or MDMΦ were stimulated by addition of Escherichia coli LPS (055:B5 
[1µg/mL], Sigma, St. Louis, MO). 
Alveolar macrophage isolation. AMΦ were isolated as described previously (21). 
Briefly, lungs of calves were aseptically removed at necropsy and lavaged with 500mL 
sterile PBS. The lavage fluid was centrifuged in 250mL conical tubes at 1000 x g (Beckman 
J-6B, Beckman Coulter, Indianapolis, IN) for 20 minutes at 4°C.  Cells were isolated by 
plastic adherance in 75mm petri dishes. Ice cold PBS was added to the dish and adherent 
cells were gently removed with a sterile cell scraper.  Cells were centrifuged and resuspended 
in cRPMI 1640 at a concentration of 5x106 cells per mL. AMΦ were plated in 96-well round 
bottom tissue culture plates at 5 x105/ml and incubated 2 or 24 h with LPS. 
RNA extraction and cDNA synthesis. At 2 h or 24 h post LPS stimulation, cells 
were lysed with Buffer RLT containing 2-mercaptoethanol (Qiagen, Valencia, CA) and 
stored at −80°C. Total RNA was isolated using the RNeasy Mini RNA Isolation Kit (Qiagen) 
per manufacturer’s instructions. Contaminating genomic DNA was removed during RNA 
isolation using an on-column RNase-Free DNaseI digestion set (Qiagen) according to 
manufacturer’s instructions. Total RNA was eluted by the addition of 40 µL of DNase–
RNase free water with addition of RNAse OUT (Invitrogen, Carlsbad, CA) for increased 
RNA stability. RNA was quantified using a NanoDrop 2000 Spectrophotometer (Thermo 
Scientific). 500 ng of total RNA from each sample was reverse transcribed using random 
primers/hexamers and Superscript III (Invitrogen) according to manufacturers instructions. 
Real time PCR. Primers were designed specifically for SYBR Green chemistry with 
the use of Primer Express v 3.0 (Applied Biosystems, Foster City, CA) or NCBI Primer Blast.  
Primer annealing temperature was set at 60°C with product size of 100-200 base pairs. 
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Bovine ribosomal protein S9 (RPS9) was used as the endogenous control (15). Primer set 
sequence are as follows: RPS9 Forward 5’- CGC CTC GAC CAA GAG CTG AAG -3’, 
RPS9 Reverse 5’- CCT CCA GAC CTC ACG TTT GTT CC -3’; IL-1β Forward 5’- TTC 
TGT GTG ACG CAC CCG TGC -3’, IL-1β Reverse 5’- AGC ACA CAT GGG CTA GCC 
AGC -3’; TNFα Forward 5’- CGG GGT AAT CGG CCC CCA GA -3’, TNFα Reverse 5’- 
GGC AGC CTT GGC CCC TGA AG -3’; IL-6 Forward 5’- CTG AAG CAA AAG ATC 
GCA GAT CTA-3’, IL-6 Reverse 5’- CTC GTT TGA AGA CTG CAT CTT CTC -3’.  An 
Applied Biosystems 7300 Real Time PCR Systems thermocycler was used.  Amplification 
conditions for all genes were the same: 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s 
95°C and 1 min 60°C (measure florescence step) and a dissociation step of 15 s 95°C, 1 min 
60°C, 15 s 95°C, 15 s 60°C. Ct values were calculated and normalized to the endogenous 
control and expressed relative to medium only treatment using the 2-ΔΔCT method (44). 
Dissociation curves were analyzed for proper product amplification. 
Multiplex cytokine immunoassay. 50 µL of monocyte or macrophage (MΦ) 
supernatants or cytokine standards were incubated for 3 h in duplicate in 96 well, 
immobilized antibody 6-plex array plates (SearchLight, Aushon Biosystems, Billerica, MA). 
Wells of each plate were commercially coated with antibodies specific for bovine interleukin 
(IL)-2, IL-4, IL-1β, tumor necrosis factor (TNF)-α, IL-6 and interferon (IFN)-γ. The assay 
was conducted according to manufacturer’s instructions.  After chemiluminescent substrate, 
plates were immediately read on a SearchLight Plate Reader (Aushon Biosystems).  The 
concentrations of cytokines in each sample were determined from standard curves using 
SearchLight Array Analyst Software v 2.6.2.0 (Aushon Biosystems). The lower limits of 
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detection for the cytokines were (pg/mL): IL-2=6.1, IL-4=0.8, IL-1β=1.9, TNFα=2.4, IL-
6=0.9, and IFNγ=0.5. 
Western blotting. Lysates were generated for western blot analysis at 24 h post LPS 
stimulation. 50 µL of lysis buffer (BD Pharmingen) with Halt Protease/Phosphatase and 
0.5M EDTA (Thermo Scientific) was added directly to wells.  Lysates were stored at -80°C 
until analysis.  For western blot analyses, lysates were quantified using a NanoDrop 2000 
Spectrophotometer (Thermo Scientific) and standardized to 10ug protein concentrations. 
Samples were diluted 1:1 with Laemmli Loading Buffer (Thermo Scientific) containing 2-
mercaptoethanol.  Samples were heated at 95°C for 5 min.  Heated samples (20uL) and 
Benchmark Prestained Protein Ladder (Invitrogen) were loaded into a Novex Tris-Glycine 
1.0mm 15 well gels (Invitrogen) and electrophoesed at 75V for approximately 1.5 h or until 
distinct ladder separation had occurred.  Gels were transferred to nitrocellulose using an iBlot 
transfer system (Invitrogen) per manufacturer’s recommendations.  Nitrocellulose was 
incubated in StartingBlock blocking buffer (Thermo Scientific) at room temperature for 30 
min prior to addition of primary antibody.  Rabbit mAb Anti-MyD88, Anti-TRIF and mouse 
mAb Anti-phospho IKKαβ, Anti-total IKKβ, Anti-β-actin, (Cell Signaling Technologies) 
were diluted (1:2000) in StartingBlock blocking buffer with 0.05% Tween-20 (Sigma) and 
incubated on nitrocellulose blot overnight at 4°C with gentle agitation.  The blot was washed 
in Tris Buffered Saline containing 0.1% Tween-20 (TBST).  HRP-secondary (anti-species 
specific to primary antibody) was used at 1:10000 in StartingBlock blocking buffer with 
0.05% Tween-20 and incubated for 60 minutes with gentle agitation at room temperature.  
Blots were washed with TBST prior to addition of Dura Extended Signal 
Chemiluminescence Substrate (Thermo Scientific) and incubated for 5 min with gentle 
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agitation.  Blots were imaged using Searchlight Imager (Aushon Biosystems) and analyzed 
using ImageJ (NIH).  Restore Plus Buffer (Thermo Scientific) was used according to 
manufacturers instructions to strip blots prior to re-blotting. Western blot data were 
normalized to β-actin for semi-quantification using densitometry (ImageJ, NIH, Bethesda 
Maryland). 
Production of BVDV NS5A antiserum. An internal fragment of the NS5A protein 
of BVDV 2 strain 1373 (nucleotides 9296 through 9964) was amplified by PCR using 
primers that added BamHI (5') and SalI (3') restriction sites.  The fragment was cloned into 
the prokaryotic expression vector pMAL-C1 (New England Biolabs, Beverly, MA) that 
produced a 24.5 kDa NS5a protein fused to maltose binding protein.  The fusion protein was 
purified by standard procedures and used to immunize rabbits.  Two rabbits were immunized 
and boosted once during antiserum generation.  Approximately 20mLs of antiserum was 
harvested from each animal. 
Co-immunoprecipitation. Immunoprecipitations were performed per manufacturers 
instruction (Thermo Scientific) using the IP Crosslinking Kit. BVDV NS5A antibodies were 
bound to Protein A/G beads of the column.  Briefly, lysates were incubated overnight on 
column with collection of unbound lysate saved. A high pH elution for 5 minutes and 
regeneration of the columns was performed.  The IP lysate was loaded into a 10-20% Tris-
Glycine gel (Invitrogen) and protein separated at 120V.  The proteins were transferred to 
nitrocellulose and blocked with StartingBlock Blocking Buffer (Thermo Scientific). The 
blots were probed using rabbit monoclonal anti-MyD88 antibody (1:1000 dilution; Cell 
Signaling Technologies) followed by anti-rabbit HRP secondary (1:500) (Thermo Scientific). 
Femto Signal Chemiluminescence Substrate (Thermo Scientific) was used for development. 
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Statistical Analysis. qPCR cytokine data was analyzed with the outcome variable (2-
ΔΔCT) log transformed. ΔΔCt values were analyzed using two-way ANOVA (Prism, 
GraphPad, LaJolla, CA) with sources of variation experimental infection and cell culture 
treatment. Bonferroni post test was used to compare replicate means by row to uninfected 
controls. Cytokine protein data was analyzed using two-way ANOVA (Prism, GraphPad) 
with sources of variation experimental infection and cell culture treatment with Bonferroni 
post test was used to compare replicate means by row to uninfected controls.   Results are 
expressed as means +/- standard errors of the means (SEM). 
 
RESULTS 
Circulating monocytes are not depleted in calves infected with BVDV-2 strains 
of high or low virulence. Previous studies have shown that peripheral blood monocytes are 
not depleted during BVDV-2 infection (40, 41). Lymphopenia was observed in calves 
infected with high or low virulence BVDV-2 strains (McGill et al., manuscript in 
preparation).  Monocyte levels were not significantly reduced in circulation during the course 
of BVDV-2, although there was a reduction in monocytes isolated from the 1373 infected 
calves at day 12 post infection (Table 1). The decrease observed for day 12 was not seen at 
day 14 or observed at any other time point measured (data not shown).  This data, as well as 
data from others, suggest that there is no sustained depletion of peripheral blood monocytes 
throughout the time course of BVDV-2 infection. 
Monocytes isolated from BVDV-2-infected calves early in BVDV-2 infection 
display enhanced cytokine responses to LPS stimulation. Given that over the course of the 
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infection peripheral blood monocytes were not substantially depleted, we examined whether 
there was a modulation of cytokine responses of monocytes as a result of BVDV-2 infection.  
The basis for this idea was a previous study which demonstrated that in vitro ncp BVDV-1 
infection downregulates TNFα, IL-1β and IL-6 gene expression in monocytes (37); however, 
the effects of in vivo BVDV-2 infection have not yet been examined with respect to 
monocytes and cytokine production. We investigated TNFα, IL-1β and IL-6 mRNA 
responses prior to and after LPS stimulation at 2 h or 24 h as these cytokines will have an 
early, sustained mRNA response (81). It is noteworthy that unstimulated monocytes from the 
HV BVDV-2-infected calves had significantly higher IL-1β and IL-6 RNA levels than 
monocytes from uninfected calves.  Interestingly, at 2 h post LPS simulation monocytes 
isolated from HV and LV infected animals exhibited enhanced TNFα mRNA transcription 
compared to monocytes from uninfected animals (Fig 1A). Likewise monocytes isolated 
from HV BVDV-2-infected calves exhibited enhanced IL-1β and IL-6 compared to cells 
from uninfected controls (Fig. 1A). There was no increase in LPS-stimulated IL-1β or IL-6 
mRNA in monocytes isolated from the LV BVDV-2-infected calves compared to the 
uninfected control monocytes. At 24 h (Fig. 1B), TNFα was greater in monocytes isolated 
from the HV BVDV-2 calves compared to uninfected controls, although there was no 
enhancement of mRNA following LPS stimulation.  Upregulation of IL-1β and IL-6 mRNA 
was observed in monocytes isolated from the HV BVDV-2-infected group (Fig. 1B). 
Monocytes isolated from the LV BVDV-2 group exhibited enhanced IL-1β mRNA 
expression with LPS treatment. Furthermore, we examined levels of cytokine secretion as 
shown in Fig. 1C.  Interestingly, monocytes isolated from the LV BVDV-2 group secreted 
significantly higher levels of TNFα and IL-1β following LPS stimulation compared to 
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monocytes from uninfected calves. Taken together, the results show that monocytes isolated 
early in BVDV-2 infection have upregulated proinflammatory cytokine mRNA prior to LPS 
stimulation and produce higher levels of cytokines in response to LPS than cells from 
uninfected controls. 
Monocytes isolated from BVDV-2-infected calves late in infection exhibit 
enhanced inflammatory cytokine responses to LPS. An examination of day 12 post-
infection was chosen as this represents the recovery phase following LV BVDV-2 infection 
(42), which is not observed for HV BVDV-2-infected calves (40).  In unstimulated monocyte 
cultures there was an increased expression of TNFα, IL-1β and IL-6 in monocytes isolated 
from HV and LV BVDV-2-infected groups compared to cells from uninfected calves (Fig. 
2A and B). At 2 h post LPS stimulation, monocytes from HV BVDV-2-infected calves 
exhibited enhanced mRNA for TNFα, IL-1β and IL-6 compared to monocytes from the 
controls. Increased TNFα and IL-1β gene expression was observed in monocytes isolated 
from the LV BVDV-2 group in response to LPS.  Interestingly TNFα mRNA was not 
enhanced after 24 h LPS stimulation in monocytes isolated from either BVDV-2-infected 
group (Fig. 2B). Monocytes isolated from the HV BVDV-2 group with LPS treatment 
exhibited enhanced IL-1β and IL-6 at 24 h compared to cells from uninfected calves.  
Downregulation in IL-1β mRNA expression was seen after 24 h LPS stimulation in 
monocytes isolated from the LV BVDV-2-infected group compared to those from uninfected 
controls; however, the monocytes did exhibit enhanced IL-6 after 24 h LPS stimulation.  
Monocytes isolated from the HV BVDV-2-infected animals stimulated 24 h with LPS 
exhibited an enhanced TNFα, IL-1β and IL-6 secretion compared to monocytes from 
uninfected calves (Fig. 2C).  Secretion of TNFα and IL-1β in response to LPS stimulation of 
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monocytes isolated from the LV BVDV-2 group was similar to monocytes from uninfected 
calves, while IL-6 was significantly higher.  In summary, proinflammatory cytokine levels 
seen in monocytes isolated from HV BVDV-2-infected calves were higher than observed for 
monocytes isolated from LV BVDV-2-infected or control calves. 
MΦ derived from monocytes early in BVDV-2 infection display decreased 
cytokine mRNA and protein responses to LPS. Monocytes differentiate into macrophages 
that play a pivotal role during infection via recognition of PAMPs and initiation of innate 
immune signaling pathways, and the effects of an in vivo BVDV-2 infection on this 
development of a MDMΦ has not been investigated.  We examined the influence of BVDV-2 
infection on the cytokine expression of monocytes differentiated into MΦ and the LPS 
responsiveness of these cells.  Unstimulated MDMΦ from HV BVDV-2-infected calves had 
significantly enhanced TNFα mRNA compared to uninfected controls; however, MDMΦ 
isolated from HV or LV BVDV-2 groups did not upregulate TNFα mRNA expression in 
response to 2 h LPS stimulation (Fig. 3A). Interestingly, MDMΦ isolated from the HV 
BVDV-2 group exhibited a decrease in mRNA expression in response to 2 and 24 h LPS 
stimulation for IL-1β and IL-6 compared to cells from the uninfected group (Fig. 3A and B). 
MDMΦ from the LV BVDV-2 group exhibited an enhanced mRNA expression of TNFα in 
response to 24 h LPS stimulation compared to the controls.  There was no significant 
difference in TNFα secretion between the HV or LV BVDV-2-infected groups compared to 
contols in response to LPS (Fig. 3C).  However; secretion of IL-1β and IL-6 in response to 
LPS stimulation of MDMΦ from both HV and LV BVDV-2-infected groups was decreased 
compared to cells from the uninfected animals.  In general, early in infection, LPS-stimulated 
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MDMΦ from HV BVDV-2-infected calves display reduced proinflammatory cytokine 
responses compared to cells from uninfected calves. 
MΦ derived from monocytes late in BVDV-2 infection have decreased levels of 
cytokine mRNA and protein secretion in response to LPS. At day 12 post BVDV-2 
infection unstimulated MDMΦs from both HV and LV infected groups exhibited a decrease 
in TNFα mRNA compared to the uninfected group (Fig. 4A and B).  Likewise, MDMΦ 
isolated from the HV and LV BVDV-2-infected calves exhibited a downregulation in TNFα 
and IL-1β mRNA expression after 2 or 24 h LPS stimulation compared to cells from 
uninfected calves. However, IL-6 mRNA was enhanced after 2 or 24 h LPS stimulation in 
MDMΦ isolated from the HV BVDV-2 group compared to cells from the uninfected group 
(Fig 4A and B).  Conversely, IL-6 mRNA was reduced in response to 2 or 24 h LPS 
stimulation from MDMΦ isolated from the LV BVDV-2-infected group compared to 
controls. TNFα protein secretion was decreased in MDMΦ isolated from the HV BVDV-2-
infected group after LPS stimulation compared to MDMΦ from the uninfected group (Fig. 
4C). MDMΦ from both HV and LV BVDV-2-infected groups exhibited decreased IL-1β 
protein secretion in response to LPS stimulation compared to cells from uninfected controls. 
IL-6 protein secretion was enhanced in MDMΦ isolated from the HV BVDV-2-infected 
group in response to LPS stimulation compared to the MDMΦ isolated from the uninfected 
group; although, MDMΦ from the LV BVDV-2-infected group demonstrated no change 
from controls.  To summarize, MDMΦ from HV and LV BVDV-2 infected-calves were 
shown to have reduced expression of proinflammatory cytokines compared to MDMΦ 
isolated from control animals and similarly a decrease in LPS responsiveness as evidenced 
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by a reduction in proinflammatory cytokine mRNA transcription and reduced cytokine 
secretion. 
AMΦ from BVDV-2-infected calves exhibit a reduced proinflammatory cytokine 
mRNA response to LPS. As we observed lung lesions in the HV and LV BVDV-2-infected 
calves (data not shown), we investigated the effect of BVDV-2 infection on the AMΦ and the 
LPS responsiveness of these cells. AMΦ are a tissue macrophage that can develop from 
circulating monocytes and are resident in the lung in which these cells act as sentinels to 
pathogens (15). Interestingly unstimulated AMΦ isolated from both HV and LV BVDV-2 
groups exhibited decreased mRNA expression of IL-6 and after 2 h LPS stimulation 
compared to cells from uninfected controls (Fig 5A and B).  TNFα and IL-1β mRNA 
expression was enhanced at 2 h in AMΦ isolated from the LV BVDV-2 group in response to 
LPS stimulation compared to that in AMΦ from the uninfected group.  At 24 h post LPS 
stimulation, AMΦ isolated from the HV BVDV-2-infected calves exhibited reduced 
expression of TNFα mRNA compared to that of cells from the uninfected calves (Fig. 5B). 
Cytokines secreted by the AMΦ from HV and LV BVDV-2-infected groups in response to 
LPS did not significantly differ from uninfected control cells, except for the LV group which 
secreted significantly less IL-6 (Fig. 5C). In general, LPS-stimulated proinflammatory 
cytokine mRNA expression from AMΦ isolated from BVDV-2-infected calves is decreased 
compared to AMΦ control calves. 
Myeloid cells from BVDV-2 infected calves differentially express cytokine 
mRNA and protein. To summarize the differences in cytokine expression in BVDV-2-
infected calves prior to and after LPS stimulation, a diagram representative of each myeloid 
cell type is shown in Fig. 6.  Representative results from day 12 post BVDV-2 infection are 
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shown with changes in mRNA and protein compared to uninfected cells as at this timepoint 
the greatest contrast in cytokine profiles were observed.  Generally, BVDV-2 alone induced 
an increase in each cytokine measured in the monocytes isolated from infected calves.  
However, TNFα was expression decreased in MDMΦ and IL-6 was decreased in AMΦ 
isolated from BVDV-2-infected calves.  There was no change in protein expression of any of 
the cell types isolated from BVDV-2-infected calves compared to controls prior to LPS 
stimulation.  After LPS stimulation, proinflammatory cytokine gene expression and protein 
was enhanced in monocytes isolated from BVDV-2-infected calves compared to controls. 
TNFα and IL-1β were reduced in expression after LPS stimulation in MDMΦ isolated from 
BVDV-2 infected calves, whereas IL-6 mRNA and protein was enhanced compared to 
controls.  AMΦ isolated from BVDV-2-infected calves and stimulated with LPS exhibited 
increased mRNA expression of TNFα and IL-1β; however decreased expression of IL-6 
mRNA was observed.  Similarily, LPS-induced IL-6 secretion was lower in AMΦ isolated 
from infected calves compared to AMΦ from control calves. 
MyD88 protein expression is modulated in MDMΦ isolated from HV infected 
calves. Bacterial LPS can signal through TLR4 which involves adapter protein MyD88-
dependent or MyD88-independent TRIF/TRAM pathways (49) . We examined expression of 
MyD88 and TRIF in myeloid lineage cells isolated at day 12 post BVDV-2 infection. 
Monocytes isolated from the HV infected calves (Fig. 7A) demonstrated reduced MyD88 
expression after LPS treatment. MDMΦ isolated from the HV infected calves demonstrated 
the greatest amount of decrease in expression of MyD88 either with or without LPS 
stimulation (Fig. 7B). AMΦ from both the HV and LV infected groups exhibited a decrease 
in MyD88 after LPS stimulation (Fig. 7C).  Further, we investigated expression of TRIF, 
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which can signal independently of MyD88 following LPS stimulation (74) and we did not 
observe any measurable difference between the in vivo treatment groups (Fig. 7A, B and C).  
To summarize, MyD88 expression in MDMΦ was downregulated prior to stimulation and 
after LPS treatment, myeloid cells isolated from BVDV-2-infected animals did not 
upregulate MyD88 to the same extent seen in cells from uninfected animals with the MDMΦ 
demonstrating the lowest expression of MyD88. 
BVDV NS5A interacts with MyD88. We established that there was a modulation of 
MyD88 expression in myeloid lineage cells isolated from BVDV-2-infected calves. 
Moreover, it was reported that HCV NS5A colocalizes with MyD88 (1).  Additionally, given 
that there are tertiary structural similarities between the NS5A proteins of BVDV and HCV 
(54), we examined whether BVDV-2 NS5A binds to adapter protein MyD88.  We 
immunoprecipitated MDMΦ whole cell lysates with a BVDV NS5A antiserum and then 
blotted with an anti-MyD88 mAb (Fig 8A).  In cells from HV or LV BVDV-2-infected 
animals, we determined that NS5A interacts with MyD88. The unbound NS5A flow-through 
fraction probed with the MyD88 mAb is shown in Fig 8B. 
 Myeloid lineage cells from BVDV-2-infected calves differ in their expression of 
phosphorylated IKKβ  in response to LPS. TLR4 ligation upregulates transcription of 
NFκB family members which ultimately give rise to proinflammatory cytokines (27).  A 
previous study demonstrated that BVDV-1 inhibited the phosphorylation of the IKKβ 
subunit of the IKK signaling complex to block NFκB signaling in an epithelial cell line (80).  
Monocytes isolated from BVDV-2-infected calves (Fig. 9A) exhibited increased expression 
of phosphorylated(p)-IKKβ in response to LPS to a similar extent as uninfected control cells.  
Interestingly, we observed a decrease in p-IKKβ in response to LPS in MDMΦ from animals 
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infected with BVDV-2 (Fig. 9B).  Similarily, AMΦ (Fig. 9C) from the BVDV-2-infected 
animals were found to have a lower expression of p-IKKβ compared to cells isolated from 
control animals.  These data show that MΦ from HV and LV BVDV-2-infected animals are 
unable to express phosphorylated IKKβ in response to LPS to the same extent as cells 
isolated from uninfected calves. The lack of increased p-IKKβ in MΦ stimulated with LPS 
may partially explain the observed downregulation of cytokine gene expression. 
 
DISCUSSION 
Experimental infection with LV BVDV-2 strain RS886 induced mild to no clinical 
signs as previously reported (41).  By comparison, HV ncp BVDV-2 strain 1373-infected 
calves exhibited more severe clinical signs including high fever, diarrhea, signs of depression 
and recumbency (40).  While lymphocytopenia was seen following challenge with these 
BVDV-2 strains, monocytes were not significantly depleted (Table 1) (40, 41). Given that 
circulating pools of monocytes are maintained during BVDV-2 infection, functional 
modifications may be targeted, as these cells differentiate into tissue macrophages following 
their exit from circulation and secrete inflammatory cytokines vital to innate host defenses. 
BVDV can be a contributing factor in bovine respiratory disease complex (BRDC) as it 
enhances susceptibility to secondary infection via immunosuppression (14).  Critical to the 
induction of inflammatory cytokines in response to bacterial infection are PRRs, such as 
TLRs, expressed on multiple cell types which recognize evolutionarily conserved PAMPs.  
By studying the effects of BVDV-2 on subsequent TLR4 signaling in myeloid lineage cells 
we sought to unravel specific mechanisms whereby viral infection may alter host responses 
to secondary bacterial infections.   
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There have been few studies published on the effects of BVDV infection on the 
cytokine response of monocytes and these studies have examined BVDV-1 infection in vitro.  
An earlier study examined the effects of BVDV-1 on monocytes infected in vitro in which no 
differences were seen between the intensities of the hybridization signals of IL-1 obtained 
using RNA extracted from LPS-stimulated BVDV-infected and uninfected monocytes. 
However there was a demonstration of inhibition of IL-1 activity in monocyte supernatants 
as supported by significant suppression of mouse thymocyte proliferation when compared to 
uninfected control supernatants (31).  More recently, it has been shown in vitro that BVDV-1 
infection of monocytes resulted in reduced IL-1β and IL-6 mRNA transcription and 
decreased IL-1β, IL-6 and TNFα secretion compared to uninfected controls (37).  To date, 
the effects of Flaviviral infection on LPS responsiveness of monocytes has been examined in 
studies with HCV or Dengue virus. Peripheral blood monocytes isolated from individuals 
chronically infected with HCV and stimulated with LPS exhibited enhanced expression of 
TNFα, IL-1β and IL-6 protein compared to aviremic or uninfected individuals (17, 76). 
Moreover, human monocytes infected with Dengue virus and stimulated with LPS were 
found to secrete high levels of IL-1β, TNFα, IFNα, IL-6, IL8, IL-12, MIP-1α and RANTES 
compared to uninfected control cells (7, 10).  
We established that monocytes isolated from BVDV-2-infected animals generally 
exhibited enhanced TNFα, IL-1β and IL-6 mRNA compared to cells from uninfected animals.  
Similarly, monocytes isolated from BVDV-2-infected calves demonstrated an increase in 
expression of TNFα, IL-1β and IL-6 mRNA and protein secretion in response to LPS 
stimulation throughout the course of infection compared to monocytes isolated from 
uninfected calves. Furthermore, TNFα and IL-1β secretion in response to LPS stimulation 
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was significantly elevated in monocytes from HV BVDV-2 infected calves late in infection. 
Hypersensitivity of PRRs and enhanced expression of proinflammatory cytokines are 
contributing factors to severe clinical disease and a prolonged period of recovery (12, 68, 70, 
72).  Noteworthy is that in HV BVDV-2 infection, recovery is prolonged compared to LV 
BVDV-2 (40). The observed increase in proinflammatory cytokine secretion in response to 
LPS-stimulation by monocytes following BVDV infection would be predicted to contribute 
to more severe clinical BRDC. Enhanced pro-inflammatory cytokine secretion from 
monocytes has been seen in cases of viral infection with associated peripheral lymphocyte 
depletion or increased induction of leukocyte apoptosis (25, 28, 60). These data and those of 
others (7, 10, 17, 18, 76) indicate that monocytes from Flaviviral-infected hosts have an 
increase in expression of proinflammatory cytokine mRNA and are hyperresponsive to LPS 
stimulation as this may be contributory to inflammation following secondary infection. 
Monocytes differentiate into macrophages and during maturation upregulate 
expression of TLRs as well as other PRRs (38).  In response to TLR stimulation, 
macrophages become classically activated in which they secrete proinflammatory cytokines 
such as TNFα, IL-1β and IL-6, as well as produce reactive nitrogen and superoxide 
intermediates, promote TH1 responses, and increase microbicidal, tumoricidal and antiviral 
activity (48, 61).  Previous studies have explored the impact of Flaviviradae on the TLR 
responsiveness of in vitro derived MΦ.  Bone marrow derived macrophages (BMMΦ) 
infected with BVDV-1 in vitro have been shown to secrete less TNFα protein in response to 
LPS or bacterial infection compared to uninfected BMMΦs (2).    TLR hyporesponsiveness 
has been demonstrated in MDMΦ from chronically infected HCV patients which correlated 
to more severe disease and worse clinical outcome (13, 43).  Yellow fever virus (YFV) and St. 
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Louis Encephalitis Virus (SLEV) infection reduced IL-1β levels in LPS-stimulated MDMΦ 
compared to uninfected control cells (5). We found that MΦ derived during BVDV-2 
infection generally have reduced inflammatory cytokine mRNA.  Likewise, mRNA and 
protein secretion following LPS stimulation compared to uninfected cells was decreased in 
MDMΦ derived from BVDV-2-infected calves.  However, MDMΦ derived late in infection 
from HV BVDV-2 infected calves produced enhanced IL-6 in response to LPS compared to 
cells from uninfected animals. A TH2 biased response has been implicated as a potentiating 
factor in the susceptibility to certain secondary pathogens observed in BRDC (35, 73). Given 
that IL-6 is a pleiomorphic cytokine which can contribute to TH2 responses, our observation 
of increased IL-6 from LPS-stimulated MDMΦ HV BVDV-2-infected calves may be one 
contributing factor to this bias.  Together with previous studies (5, 13, 43), these results 
suggest that in vitro-derived terminally differentiated macrophages have a decreased 
proinflammatory cytokine mRNA profile and a reduced ability to respond to TLR4 ligation 
following infection with Flaviviruses.  
Macrophages which reside in specific tissues of the host act as sentinels in the 
detection of invading pathogens (15). AMΦ are a terminally differentiated tissue macrophage 
resident to the alveolar spaces of the lung, which further play roles in lung homeostasis as 
well as tissue remodeling following lung damage (9).  These cells respond to pathogens 
through production of proinflammatory cytokines (15) and are of interest to BVDV-2 
infection in the lung as these cells will be one of the first innate immune cells to encounter 
the virus.   One study has shown that in vivo BVDV-1 infection with in vitro restimulation 
with BVDV-1 of AMΦ greatly reduced normal function of these cells, with a decline in their 
ability to secrete neutrophil chemotactic factors, a downregulation of Fcg receptor and CR3 
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expression, and a reduction in phagocytic capability (75).  Likewise, a study has 
demonstrated TLR4 responsiveness was decreased in Kupffer cells incculated with HCV 
viral proteins from HCV-infected patients as evidenced by a reduction in IL-1β secretion (29).  
It is interesting to note that AMΦ isolated from BVDV-2-infected calves demonstrated a 
decrease in expression of IL-6 mRNA compared to cells isolated from control calves.  On the 
other hand, our results indicate that AMΦ isolated from BVDV-2-infected calves are similar 
to AMΦ from control calves in their ability to secrete TNFa and IL-1b following LPS 
stimulation.  It is of note that AMΦ isolated from LV BVDV-2-infected group had 
significantly decreased IL-6 secretion in response to LPS compared to AMΦ from uninfected 
controls.  The implication of these observations is that proinflamatory cytokine production by 
AMΦ in response to LPS could play a role in increased susceptibility of the lung to 
secondary infection, as well as contribute to the pathogenesis resulting from these infections 
(4, 66, 77). As such, AMΦ-derived pro-inflammatory cytokines may be a contributing factor 
in BRDC. 
 MyD88 is an adapter protein important for TLR1/2, 2/6, 4, 7/8, 9 as well as IL-1 
receptor signaling, as it bridges the cytosolic-exposed tails of these receptors to signaling 
molecules downstream of activation (20).  These signaling pathways, with the exception of 
TLR 7/8, are critical to bacterial sensing.  Worth noting is that there is a 2-3 fold decrease in 
expression of MyD88 in monocytes compared to matured MΦs, indicated that there are 
phenotypical changes occurring during culture of monocyte toward a MDMΦ (38).   
Similarily it has been shown that monocytes preferentially signal through TRIF mediated 
MyD88-independent signaling although a differentiated MΦ may be prone to MyD88-
dependent signaling (65).  There are no studies exploring the impact of BVDV infection on 
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MyD88 expression, however some viruses are known to interact with the TIR domains of 
MyD88.  VV protein A46 interacts with MyD88 and Mal through electrostatic interactions 
blocking complex formation after activation of TLRs (45, 62).  Likewise, it has been shown 
AMΦ from asymptomatic HIV+ individuals are impaired in their MyD88-dependent TLR4 
cytokine response by blocking the MyD88-IRAK interaction, phosphorylation of IRAK and 
subsequent NFκB translocation and proinflammatory cytokine secretion, which the authors 
suggested may be linked to increased bacterial pneumonia (64).  Our studies have identified 
MyD88 as a target of BVDV-2 as MyD88 protein expression is decreased in LPS-stimulated 
myeloid cells isolated from the HV BVDV-2-infected groups. The greatest reduction in 
expression of MyD88 was in MDMΦ from BVDV-2-infected calves compared to MDMΦ 
from uninfected controls. Similarly, monocytes and AMΦ failed to upregulate MyD88 in 
response to LPS as observed in cells isolated from uninfected animals.  TRIF was not 
significantally different between the myeloid cells isolated from the virally infected groups 
compared to the cells from uninfected controls.  One explanation of how myeloid cells differ 
in responsiveness to LPS stimulation in induction of cytokine mRNA expression is through 
TRIF mediated MyD88-independent pathways (65). The data suggests that viral infections 
which lead to increased susceptability to secondary bacterial infections may target TLR 
pathways or MyD88 adaptor molecules in myeloid cells (45, 62, 64). 
NS5A is a polyprotein essential for BVDV replication as it is critical to the replicase 
complex and during viral replication NS5A can be found in abundance within an infected cell 
(8, 54). HCV and BVDV NS5A also share structural similarities such as a common essential 
zinc binding region (67) and association with cellular membranes via an amino-terminal 
helix (59). As the BVDV NS5A membrane anchor has been determined, molecular dynamic 
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simulations suggest that this helix interacts with membranes in a manner similar to that of the 
HCV NS5A anchor (59). HCV and BVDV NS5A are also phosphorylated through cdc2 
cyclin-dependent kinases (54, 79).  These data suggest that BVDV and HCV NS5A proteins 
are similar in both structure and function. Interestingly, HCV NS5A has been shown to 
interact with MyD88 in an in vitro study (1, 18, 58).  We have demonstrated that BVDV 
NS5A from an in vivo infection interacts with MyD88.  There have been no studies 
comparing sequences between the NS5A gene of varying BVDV-2 strains, although this may 
be a point in which genetic variability between the HV and LV viruses could effect 
expression of NS5A.  However, it is plausible that BVDV-2 NS5A binding to MyD88 
produces steric hindrance, inhibiting the interaction of this adapter protein with the IRAK 
and TRAF6 as described for VV (45, 62). 
Downstream of the MyD88 adaptor protein are IKK complexes critical to the 
induction of transcription factors in the regulation of proinflamatory cytokine responses.  
After phosphorylation of the IKK complex, the inhibitor of NFκB, IκB (IκBα) is degraded, 
freeing NFκB to translocate into the nucleus of the cell and induce gene transcription.  
Previous reseach has demonstrated BVDV-1 can block IKKβ phosphorylation (80), which in 
turn inhibits transcription factor NFκB family members from becoming activated.  Similarly, 
HCV has been shown to interfere with IKKβ kinase activity and IKK complex translocation 
via HCV core protein (32).  Interestingly inhibition of IKKβ kinase activity in BVDV-1 (80) 
and HCV (53) increases viral replication through a mechanism yet to be elucidated.  This 
suggests that IKKβ is an import factor in Flaviviral pathogenesis.  Furthermore, it has been 
observed that HCV-infected liver hepatocytes and DCs exhibit decreased NFκB activity (16, 
33, 50, 63).  We found that the expression of pIKKβ was reduced in MDMΦ from BVDV-2-
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infected calves compared to cells from uninfected calves after LPS stimulation. This 
decreased expression of pIKKβ in MDMΦ is similar to data from others showing a 
downregulation of NFκB in BVDV-1-infected epithelial cells (11, 78, 80).   
We demonstrated enhancement of proinflammatory cytokine mRNA transcription in 
monocytes from BVDV-2-infected calves compared to control cells and in these cells 
following LPS-stimulation.  Conversely, we observed a deficiency in proinflammatory 
cytokine production in MDMΦ from BVDV-2-infected calves compared to uninfected 
MDMΦ and in their response to LPS-stimulation. Data from experiments with MDMΦ and 
AMΦ show a differential response in macrophages derived in vitro compared to terminally 
differentiated tissue macrophages.  Interestingly, the data in this study suggest there are 
important differences between myeloid lineage cells in cytokine expression following LPS 
stimulation which may be partially explained through the differences in the utilization of 
MyD88-dependent and MyD88-independent signaling pathways.  During BVDV-2 infection, 
immature monocytes may initially exhibit a hyperresponsive proinflammatory response to 
TLR4 ligation via TRIF-mediated MyD88-independent pathways, however after 
differentiation into macrophages, these cells may become less responsive.  
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TABLE 1 Total cell counts of monocytes from experimental groups at days 4 and 12 post 
BVDV-2 infection. N=6 per group from two independent experiments 
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FIG 1 LPS-stimulated cytokine mRNA and protein expression in monocytes isolated at day 
4 post BVDV-2 infection. (A and B) Cells were cultured in 96 well plates with or without 
LPS (1µg/mL) stimulation for 2 h or 24 h. Cytokine mRNA levels were measured by real 
time PCR. Data shown are the fold changes in monocyte cytokine mRNA expression relative 
to uninfected monocytes in medium only after normalizing to RPS9.  (C) Secreted cytokine 
levels were measured by SearchLight Array at 24 h post LPS stimulation. Data are means  
+/- SEM, n=6 per group from two independent experiments. * P < 0.05, ** P <0.001. 
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FIG 2 LPS-stimulated cytokine mRNA and protein expression from monocytes isolated at 
day 12 post BVDV-2 infection. (A and B) Cells were cultured in 96 well plates with or 
without LPS (1µg/mL) stimulation for 2 h or 24 h. Cytokine mRNA levels were measured by 
real time PCR. Data shown are the fold changes in monocyte cytokine mRNA expression 
relative to uninfected monocytes in medium only after normalizing to RPS9.  (C) Secreted 
cytokine levels were measured by SearchLight Array at 24 h post LPS stimulation. Data are 
means  +/- SEM, n=6 per group from two independent experiments. * P < 0.05, ** P <0.001. 
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FIG 3 LPS-stimulated cytokine mRNA and protein expression from MDMΦ isolated at day 
4 post BVDV-2 infection. (A and B) Cells were cultured in 96 well plates with or without 
LPS (1µg/mL) stimulation for 2 h or 24 h. Cytokine mRNA levels were measured by real 
time PCR. Data shown are the fold changes in monocyte cytokine mRNA expression relative 
to uninfected monocytes in medium only after normalizing to RPS9.  (C) Secreted cytokine 
levels were measured by SearchLight Array at 24 h post LPS stimulation. Data are means  
+/- SEM, n=6 per group from two independent experiments. * P < 0.05, ** P <0.001. 
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FIG 4 LPS-stimulated cytokine mRNA and protein expression from MDMΦ isolated at day 
12 post BVDV-2 infection. (A and B) Cells were cultured in 96 well plates with or without 
LPS (1µg/mL) stimulation for 2 h or 24 h. Cytokine mRNA levels were measured by real 
time PCR. Data shown are the fold changes in monocyte cytokine mRNA expression relative 
to uninfected monocytes in medium only after normalizing to RPS9.  (C) Secreted cytokine 
levels were measured by SearchLight Array at 24 h post LPS stimulation. Data are means  
+/- SEM, n=6 per group from two independent experiments. * P < 0.05, ** P <0.001. 
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FIG 5 Cytokine mRNA and protein expression from AMΦ isolated from calves infected with 
BVDV-2. AMΦ were isolated from lung lavage of control or BVDV-2-infected calves upon 
time of necropsy (day 14). Cells were cultured with LPS (1µg/mL) or cell culture medium for 
2 or 24 h.  Cytokine mRNA (A and B) was measured by real time PCR and bar graphs 
represent mRNA expression relative to uninfected AMΦ in medium only after normalization 
to RPS9. (C) Cell supernatants were collected at 24 h post LPS and assayed for cytokine 
protein by Searchlight array. Data are means  +/- SEM, n=6 per group from two independent 
experiments. * P < 0.05, ** P <0.001. 
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FIG 6 Summary of mRNA and protein expression data from myeloid cells isolated from 
BVDV-2 infected calves at day 12 post infection. Overall, monocytes from BVDV-2-
infected calves exhibited increased proinflammatory cytokine mRNA expression compared 
to monocytes from control animals and enhanced mRNA and protein after LPS stimulation. 
MDMΦ isolated from BVDV-2-infected calves exhibited a decrease in cytokine mRNA 
expression prior to LPS stimulation and decreased cytokine mRNA and protein expression 
after LPS stimulation. AMΦ from BVDV-2 infected calves displayed a decrease in IL-6 
expression compared to cells from control calves prior to LPS stimulation.  There was an 
increase in cytokine mRNA, but no change in protein secretion after LPS stimulation except 
for a decease in IL-6. ↑ indicates an increase in expression compared to uninfected control 
cells,↓ indicates a decrease in expression compared to uninfected control cells, N/C indicates 
no change from control. 
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FIG 7 BVDV infection modulates the MyD88-dependent but not the MyD88-independent 
TRIF pathway in response to LPS. (A) Monocytes were isolated from peripheral blood of 
control or BVDV-2-infected calves day 12 post infection. Cells were cultured LPS (1µg/mL) 
or cell culture medium alone for 24 h.  Lysates were harvested and immunoblotted with 
antibodies against MyD88, TRIF or β-actin. Densitometry scans of MyD88 or TRIF relative 
to β-actin are shown in the bar graphs.  (B) MDMΦ were isolated from peripheral blood of 
control or BVDV-2-infected calves day 12 post infection.  After maturation, MDMΦs were 
cultured with LPS (1µg/mL) or cell culture medium for 24 hours. (C) AMΦ were isolated 
from lung lavage of control or BVDV-2 infected calves upon time of necropsy (day 14). 
AMΦs were cultured with LPS (1µg/mL) or cell culture medium for 24 h. Data are means +/- 
SEM, n=3 from one experiment. 
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FIG 8 BVDV NS5A co-localizes with MyD88 with or without LPS stimulation. MDMΦ 
were isolated from peripheral blood of control or BVDV-2-infected calves day 12 post 
infection. Cells were stimulated with LPS (1µg/mL) or cell culture medium for 24 hours.  
Lysates were harvested and immunoprecipitated with beads coupled to anti-BVDV NS5A 
hyperimmunized serum. IPs were blotted with anti-MyD88 (A).  The negative fraction from 
the flow through of the IP was blotted for MyD88 (B). 
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FIG 9 Phosphorylation of IKKβ in response to LPS stimulation is reduced in myeloid 
lineage cells isolated from calves infected with a HV BVDV-2 strain. (A) Monocytes were 
isolated from peripheral blood of control or BVDV-2-infected calves day 12 post infection. 
Cells were cultured with LPS (1µg/mL) or cell culture medium alone for 24 h.  Lysates were 
harvested and immunoblotted with antibodies against phosphorylated (phospho-) IKKβ, total 
IKKβ, or β-actin. Densitometry scans of phospho-IKKβ relative to total IKK are shown in 
the bar graphs.  (B) MDMΦ were isolated from peripheral blood of control or BVDV-2-
infected calves day 12 post infection.  After maturation, MDMΦs were cultured with LPS 
(1µg/mL) or cell culture medium for 24 hours. (C) AMΦ were isolated from lung lavage of 
control or BVDV infected calves upon time of necropsy (day 14). AMΦs were cultured with 
1µg/mL of LPS or cell culture medium for 24 h. Data are means +/- SEM, n=3 per group 
from one experiment.  
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CHAPTER THREE. BOVINE FLAVIVIRADAE INFECTION 
ENHANCED CYTOKINE RESPONSES TO TLR7 LIGATION VIA JNK 
PHOSPHORYLATION WHILE REDUCING RESPONSIVENESS TO 
OTHER TLRS 
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ABSTRACT 
Bovine viral diarrhea virus (BVDV) is a member of the Flaviviradae family and infection 
may induce severe acute disease followed by immunosuppression.  As an immune 
suppressed condition may lead to enhanced susceptibility to secondary infection, it is 
possible that macrophages, which are critical in responding to pathogens, may be altered in 
their ability to respond via innate pathogen recognition receptors (PRRs).  BVDV-2 has 
varying biotypes of virulence and cytopathogenicity, which may play a correlative role in 
modulating the immune response to PRR stimulation. As such, comparison of isogenic 
BVDV-2 cytopathic/noncytopathic strains can help to elucidate how cytopathogenicity could 
affect macrophage response.  The current study demonstrates that infection of bovine 
monocyte-derived macrophages (MDMΦ) with cytopathic, noncytopathic, high and low 
virulence strains of BVDV-2 result in differential expression of pro-inflammatory cytokine 
mRNA compared to uninfected MDMΦ.  However, there was not a significant increase in 
protein secretion by macrophages in response to BVDV-2 infection, except that cytopathic 	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(cp)BVDV-2 induced IL-6.  Furthermore after MDMΦ BVDV-2 infection, cytokine 
secretion in response to toll-like receptor (TLR) 2 or TLR4 stimulation was reduced 
compared to non-infected MDMΦ.  Similarly, macrophages were hyporesponsive to viral 
TLR3 or TLR8 ligation.  Instead, TLR7 stimulation of BVDV-2 infected MDMΦ induced 
JNK1/2 phosphorylation and a unique isoform p46 was observed.  Together, these data 
suggest that BVDV-2 infection generally suppressed proinflammatory cytokine protein 
responses to bacterial sensing TLRs in MDMΦ. However infected MDMΦ responded to 
TLR7 and this may be an important pathway in viral infection.  
 
INTRODUCTION 
Bovine viral diarrhea virus (BVDV) is a single stranded, positive sense RNA virus of the 
Pestivirus genus, in the Flaviviradae family.  As such, it shares many similarities to related 
viruses such as hepatitis C virus (HCV) [1]. Infection with BVDV can range from mild to 
severe acute disease, which can be fatal.  However after recovery, BVDV infection may 
predispose the host to lifelong susceptibility to secondary bacterial or viral infection, of 
which the mechanisms of immune modulation are unknown [2].  In cattle, BVDV is a 
contributing factor to bovine respiratory disease complex (BRDC), and may contribute 
secondary infection by Mannheimia haemolytica, or Pasteurella multocida and co-infection 
of viral agents such as bovine respiratory syncytial virus (bRSV), bovine parainfluenza virus 
(boPI-3) and bovine herpes virus 1 (boHV-1) [3-6]. Thus, there is a need to understand the 
underlying mechanisms of disease and immune modulation to better develop anti-viral 
efforts toward BVDV and related Flaviviradae members. 
	   95	  
BVDV can be categorized into genotypes BVDV-1 and BVDV-2 as determined by 
genetic analysis [7].  BVDV-2 is unique as it can be highly virulent in vivo and as such can 
be classified as atypical/high virulence (HV) or typical/low virulence (LV) with disease 
severity correlating to virulence [8]. Cytopathogenicity is an in vitro and genetic trait of 
BVDV in which cp strains produce 12 functional proteins including NS2 and NS3; however 
non-cytopathic (ncp) strains produce 11 genes in which NS2/3 is produced as one whole 
protein [9].  Interestingly cytopathogenicity does not always correlate with disease severity 
and almost all BVDV infections involve ncp strains [10]. Isogenic strains of cytopathic and 
non-cytopathic BVDV can be used to elucidate differences in immune response to genetic 
variation within the NS2/3 coding region.  Furthermore, BVDV-2 has not been studied as 
well as BVDV-1 strains and potential differences in immune modulation between strains of 
differing virulence or cytopathogenicity is unknown. 
Monocytes and monocyte-derived macrophages (MDMΦ) are essential cells for the 
innate immune response to pathogens.  MDMΦ can recognize conserved molecules or 
components of microorganisms termed pathogen associated molecular patterns (PAMPs) 
[11].  PAMPs are recognized by pattern recognition receptors (PRRs), which will initiate 
proinflammatory and anti-viral immune responses.  More specifically, Toll-like receptors 
(TLRs) are a class of PRRs, which are critical to viral and bacterial sensing. As TLRs are 
conserved over mammalian species, pathogens have developed similar ways to thwart 
immune recognition by these receptors [12-14], which in turn lead to a more successful 
infection with respect to the pathogen.  
The initiation of the immune response, after recognition by TLRs, is characterized by 
cytokine secretion.  MDMΦ are one of the critical cells that secrete IL-1β, TNFα and IL-6.  
	   96	  
These pro-inflamatory cytokines have been shown to have an anti-viral role [13, 15-17] and 
as such the secretion and pathways involved in induction of these cytokines are targets of 
pathogens. BVDV-1 has been shown to downregulate pro-inflamatory cytokines in vitro 
however the cytokine response to BVDV-2 strains is unknown. 
Induction of these pro-inflammatory cytokines are dependant on phosphorylation of 
signaling complexes such as mitogen-activated protein kinase p38 (p38 MAPK), c-Jun N-
terminal kinases p46 and p54 (JNK1/2) and extracellular-signal-regulated kinases (ERK1/2) 
[18].  Blocking phosphorylation of these protein complexes are one way in which pathogens 
disrupt the signaling cascade induced by TLRs prior to cytokine transcription [19].  
Interestingly, p38 MAPK phosphorylation is greatly induced in epithelial cells inoculation 
with cpBVDV-2 strains in vitro [20], however the other pathways have not been fully 
explored. 
To date, there have been no comparitive studies of BVDV-2 strains of 
cytopathogenicity or virulence. BVDV-2 strains 296c and 296nc are isogenic except for 
differences between the coding region of NS2/3 and allowed for the first reported study of 
differences in cytokine responses in MDMΦ to these strains.  Likewise, there have been no 
comparitive studies of the effects of any BVDV strains on TLR responsiveness across a 
multitude of TLRs.  As such, TLRs are essential in recognition of both viral and bacterial 
pathogens and taken together with BVDVs effect of predisposition to secondary infection, it 
may be possible that these TLRs are severly disrupted in their function in an infection setting.  
In this study we investigated the effects of BVDV-2 infection of MDMΦ on cytokine 
expression prior to and after TLR stimulation and to the extent by which phosphorylation of 
JNK may play a roll in TLR pathway signaling. 
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MATERIALS AND METHODS 
Animals  
12 clinically healthy Holsteins of approximately 1-2 years of age were used for blood donors.  
Animals were negative for BVDV as measured by an immunohistochemistry (IHC) positive 
ear notch.  Animal procedures employed in these studies were approved by the National 
Animal Disease Center Institutional Animal Care and Use Committee. 
 
Monocyte Derived Macrophage Culture 
Peripheral blood mononuclear cells were isolated and red blood cells (RBC) lysed with 
buffered ammonium chloride salt solution.  After RBC lysis, cells were washed with sterile 
phosphate-buffered saline (PBS).  Cells were resuspended in complete RPMI 1640 (cRPMI) 
containing 10% fetal bovine serum (tested free of BVDV and antibodies against BVDV), 
2mM L-glutamine, 1% antibiotic–antimycotic solution, and gentamicin sulfate (Gibco, 
Carlsbad, CA).  Monocytes were isolated by plastic adherance.  Ice-cold PBS was added to 
the plate and adherent cells were removed with a cell scraper.  Cells were centrifuged at 1180 
x g (Sorvall RC3C Plus, Thermo Scientific, Waltham, MA), and resuspended in cRPMI 1640 
at 5x106 cells per mL.  Monocytes were plated in 96-well round bottom tissue culture plates 
in 100 µL medium. Monocytes were cultured for 7 days with media change every 2-3 days to 
derive MΦ. Cells isolated from animals were tested for BVDV through reverse transcription 
(RT)-PCR with primers selective for BVDV genotypes 1a, 1b, and 2 and were negative prior 
to experimentation. 
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Viral inoculum and TLR agonists 
BVDV-2 strains were propagated in MDBK cells with a viral titre determined by histological 
staining as follows: 296c [TCID50 6.8x106], 296nc [TCID50 3.8x108], 1373 [TCID50 
6.22x106], 28508 [TCID50 2.37x106].  Cells were inoculated with an MOI of 1.  For studies 
with TLR agonists, cells were inoculated with BVDV-2 strains for 48 h prior to TLR 
treatments.  TLR agonists were used at the following concentrations: Pam3Cys [5µg/mL] 
(Invivogen, San Diego, CA), Mannheimia haemolytica LPS [10µg/mL] (produced in house), 
Escherichia coli LPS [1µg/mL] (055:B5 Sigma, St. Louis, MO), Poly I:C [50µg/mL, Sigma], 
Imiquimod [10µg/mL] (Invivogen), ssRNA40 LyoVec [10µg/mL] (Invivogen).  Cell viability 
was measured by trypan blue exclusion and acridine orange staining prior to and after virus 
and TLR treatment. 
 
RNA extraction, cDNA synthesis and qPCR 
At 2, 6, 18, and 24 h post BVDV inoculation, cells were lysed with Buffer RLT containing 2-
mercaptoethanol (Qiagen, Valencia, CA) and stored at −80°C. Total RNA was isolated using 
the RNeasy Mini RNA Isolation Kit (Qiagen) and genomic DNA was removed during RNA 
isolation using an on-column RNase-Free DNase I digestion set (Qiagen) per to 
manufacturer’s instructions. 500 ng of total RNA from each sample was reverse transcribed 
using random primers/hexamers and Superscript III (Invitrogen) to generate first strand 
cDNA. Primers were designed specifically for SYBR Green chemistry with the use of Primer 
Express v 3.0 (Applied Biosystems, Foster City, CA) or NCBI Primer Blast.  Primer 
annealing temperature was set at 60°C with product size of 100-200 base pairs. Bovine 
ribosomal protein S9 (RPS9) was used as the endogenous control [21]. Primer set sequences 
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are indicated in Table 1. An Applied Biosystems 7300 Real Time PCR Systems thermocycler 
was used.  Amplification conditions for all genes were the same: 2 min at 50°C, 10 min at 
95°C, 40 cycles of 15 s 95°C and 1 min 60°C (measure florescence step) and a dissociation 
step of 15 s 95°C, 1 min 60°C, 15 s 95°C, 15 s 60°C. Ct values were calculated and 
normalized to the endogenous control and expressed relative to medium only treatment using 
the 2-ΔΔCT method [22]. 
 
Searchlight Cytokine Multiplex Assay 
50 µL of macrophage (MΦ) supernatants or cytokine standards were incubated for 3 h in 
duplicate in 96 well, immobilized antibody 4-plex array plates (SearchLight, Aushon 
Biosystems, Billerica, MA). Wells of each plate were commercially coated with antibodies 
specific for bovine interleukin (IL)-1β, tumor necrosis factor (TNF)-α, IL-6 and interferon 
(IFN)-γ. The assay was conducted according to manufacturer’s instructions.  After 
chemiluminescent substrate, plates were immediately read on a SearchLight Plate Reader 
(Aushon Biosystems).  The concentrations of cytokines in each sample were determined 
from standard curves using SearchLight Array Analyst Software v 2.6.2.0 (Aushon 
Biosystems). The lower limits of detection for the cytokines were (pg/mL): IL-1β=1.9, 
TNFα=2.4, IL-6=0.9, and IFNγ=0.5. 
 
Western Blots 
50 µL of lysis buffer (BD Pharmingen) with Halt Protease/Phosphatase and 0.5M EDTA 
(Thermo Scientific) was added directly to wells at specified timepoints and either analyzed 
immediately or stored at -80°C until analysis.  For western blot analyses, lysates were 
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quantified using a NanoDrop 2000 Spectrophotometer (Thermo Scientific) and standardized 
to 10µg protein concentrations. Samples were diluted 1:1 with Laemmli Loading Buffer 
(Thermo Scientific) containing 2-mercaptoethanol.  Samples were heated at 95°C for 5 min.  
Heated samples (20uL) and Benchmark Prestained Protein Ladder (Invitrogen) were loaded 
into a Novex Tris-Glycine 1.0mm 15 well gels (Invitrogen) and electrophoesed until distinct 
ladder separation had occurred.  Gels were transferred to nitrocellulose using an iBlot 
transfer system (Invitrogen) per manufacturer’s recommendations.  Nitrocellulose was 
incubated in StartingBlock blocking buffer (Thermo Scientific) at room temperature for 30 
min prior to addition of primary antibody.  Rabbit mAb Anti-MyD88, Anti-JNK, Anti-
phospho JNK (Thr183/Tyr185), or Anti-β-actin, (Cell Signaling Technologies) were diluted 
(1:2000) in StartingBlock blocking buffer with 0.05% Tween-20 (Sigma) and incubated on 
nitrocellulose blot overnight at 4°C .  The blot was washed in Tris Buffered Saline containing 
0.1% Tween-20 (TBST).  HRP-secondary (anti-species specific to primary antibody) was 
used at 1:10000 in StartingBlock blocking buffer with 0.05% Tween-20 and incubated for 60 
minutes with gentle agitation at room temperature.  Blots were washed with TBST prior to 
addition of Dura Extended Signal Chemiluminescence Substrate (Thermo Scientific) and 
incubated for 5 min with gentle agitation.  Blots were imaged using Searchlight Imager 
(Aushon Biosystems) and analyzed using ImageJ (NIH, Bethesda MD).  Restore Plus Buffer 
(Thermo Scientific) was used according to manufacturers instructions to strip blots prior to 
re-blotting. Western blot data were normalized to β-actin or JNK for semi-quantification 
using densitometry (ImageJ). 
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Statistical Analysis 
Statistical Analysis. qPCR cytokine data was analyzed with the outcome variable (2-ΔΔCT) log 
transformed. ΔΔCt values were analyzed using one-way ANOVA (Prism, GraphPad, LaJolla, 
CA). Bonferroni post test was used to compare replicate means by row to uninfected controls. 
Cytokine protein data was analyzed using one-way ANOVA (Prism, GraphPad).   Results are 
expressed as means +/- standard errors of the means (SEM). 
 
RESULTS 
Cytopathic BVDV-2 induces higher levels of proinflammatory cytokine mRNA in 
bovine MDMΦ than a noncytopathic BVDV-2 of matched isogenic type  
296c is a cp strain of BVDV-2 which is genetically identical to 296nc except for changes in 
the open reading frame of the NS2/3 gene allowing for both NS2 and NS3 to be expressed 
during 296c infections, whereas an NS2/3 read-through product is produced in 296nc [20].  
The effects of these isogenic strains on MDMΦ cytokine expression have not been examined.  
Bovine MDMΦs were differentiated for 7 days in 96 well plates and inoculated with an MOI 
of 1 for each strain with collections of subsequent time points of 2h, 6h, 18h, and 24h post- 
inoculation collected for RNA isolation.  Cytokines measured displayed similar kinetics 
throughout the duration of experiments with an initial induction of message followed by 
another induction of message at 18h post BVDV-2 inoculation (Fig. 1).  IL-1β (Fig. 1A), IL-
6 (Fig. 1C) and IL-12p40 (Fig. 1E) were induced to a greater extent in MDMΦs inoculated 
with 296c compared to 296nc at each time point measured. TNFα (Fig. 1B) and IL-10 (Fig. 
1F) were induced to a greater extent in 296c inoculated MDMΦs compared to 296nc 
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inoculation except for 6 h post treatment.  296c inoculated MDMΦs exhibited a greater 
amount of IL-8 (Fig. 1D) than 296nc inoculated MDMΦs except for 24 h post treatment. 
 Thus, MDMΦs inoculated with 296c exhibited greatly enhanced levels of 
proinflammatory cytokines.  In contract, 296nc inoculation of MDMΦs only modestly 
induced proinflammatory cytokines and was generally significantly (P<0.0001) less than the 
cytokines induced by 296c.  
 
High virulence BVDV-2 infection of MDMΦs induced greater proinflammatory 
cytokine mRNA responses compared to a low virulence strain  
BVDV-2 strains demonstrate vast differences in virulence in vivo and can be classified as 
either high/atypical or low/typical virulence strains [8]. BVDV-2 strain 1373 is a high 
virulence (HV) strain which causes severe acute disease in cattle; whereas strain 28508-5 is a 
low/typical (LV) BVDV-2 strain which causes mild to no clinical disease.  Differences 
between virulence strains and the effects on cytokine expression in macrophages have not 
been explored in vitro, and we set forth to determine differences in proinflammatory cytokine 
expression which may be induced to varying levels depending on virulence.  Interestingly, 
we found that HV 1373 induced greatly enhanced proinflammatory cytokine expression in 
inoculated cells compared to LV 28508 (Fig. 2).  However, HV 1373 induced an initial 
mRNA expression of cytokines in MDMΦs at 6h post inoculation as opposed to the other 
BVDV-2 strains in which cytokine expression was beginning to be enhanced at 2 h post 
inoculation (Fig. 1&2). IL-1β (Fig. 2A), TNFα (Fig. 2B), IL-6 (Fig. 2C), IL-8 (Fig. 2D), and 
IL-12p40 (Fig2E) were enhanced to a greater extent in MDMΦs inoculated with HV 1373 at 
6, 18, 24 h post inoculation compared to LV 28508 inoculated MDMΦs.  Additionally, IL-10 
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(Fig. 2F) was increased in MDMΦs inocualted with HV 1373 at 18 and 24 h post inoculation 
compared to LV 28508 inoculated cells. 
 Overall, HV 1373 inoculated MDMΦs demonstrated a greater level of 
proinflammatory cytokine expression starting at 6h post inoculation compared to LV 28508 
inoculated cells.  Interstingly, HV 1373 did not induce a proinflamatory cytokine response at 
2 h post inoculation compared to the other strains of BVDV-2 we used in our experiments. 
 
BVDV-2 strain 296c induced IL-6 secretion in infected MDMΦs, whereas all other 
strains did not induce secretion of proinflammatory cytokines 
Most studies of BVDV focus on mRNA expression in response to viral inoculation in vitro 
and are limited in scope of protein expression.  To date, there have been no comparative 
studies of BVDV-2 strains in vitro in which cytokine protein is explored.  As we observed an 
induction in cytokine mRNA, we investigated the protein secretion of MDMΦs in response 
to 296c, 296nc, 1373 and 28508.  Interestingly, each of the viral strains did not induce 
cytokine secretion, except for 296c (Fig. 3).  LPS was used as a positive control, and IFN-γ 
(Fig 3A), IL-1β (Fig. 3B), and TNFα (Fig. 3D) was not increased in the viral treated groups 
compared to control.  IL-6 (Fig. 3C) was increased only in the 296c treated MDMΦs 
compared to both LPS stimulated and viral inoculated cells. 
 These results suggest that there is a disconnect between mRNA expression and 
cytokine secretion in BVDV-2 inoculated MDMΦs.  It is noteworthy that although 296c did 
induce IL-6 secretion, which mirrors gene transcription, IL-1β and TNFα were not induced.  
Furthermore, it is possible that the cytopathic nature of 296c may be a factor in the induction 
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of IL-6.  Additionally, later time points of 48 h and 72 h post inoculation did not yield any 
differences in expression of secreted cytokine protein (not shown). 
 
BVDV-2 infected MDMΦs stimulated with bacterial TLR agonists exhibited reduced 
proinflammatory cytokine secretions 
With BVDV-2 stimulation alone, most of the BVDV-2 strains we tested did not induce 
proinflammatory cytokine secretion.  It would be interesting if this observation indicates a 
decrease in cytokine protein secretion in response to bacterial TLRs, as bacterial secondary 
infection can be common with BVDV-2 infection in vivo.  Few studies have investigated E. 
coli LPS responsiveness in BVDV-1 inoculated MΦ derived in vitro [23-25] and there have 
been no studies comparing varying strain of BVDV-2 to multiple types of bacterial TLRs. 
Interestingly, TNFα protein secretion was decreased in viral inoculated MDMΦs in response 
to TLR stimulation compared to TLR-stimulated uninfected controls (Fig. 4).  In MDMΦs 
inoculated with 296c or 296nc, there were no dramatically different levels of suppression 
between the groups (Fig. 4A).   Noteworthy is that both E. coli and M. haemolytica LPS 
stimulation of MDMΦs inoculated with 296c or 296nc exhibited less TNFα protein secretion 
than ones stimulated with Pam3Cys.  Similarly, MDMΦs inoculated with 1373 or 28508, 
there were no statistically different levels of suppression between the inoculated cells (Fig. 
4B). Interestingly, M. haemolytica LPS stimulation was not as suppressed in BVDV-2 
inoculated 1373 or 28508 MDMΦs as the 296c or 296nc inoculated cells. 
 In general, virulence levels and cytopathogenicity do not necessarily impact the level 
of suppression in BVDV-2 inoculated MDMΦs stimulated with bacterial TLRs, and thus are 
overall diminished in their cytokine response to bacterial TLR ligation.  Similarly, IL-1β, 
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IFNγ and to some extent IL-6 were similar in the reduced levels of secreted cytokine from 
BVDV-2 inoculated and stimulated cells (Supplemental Fig. 1 & 2). 
 
BVDV-2 infected MDMΦs respond to TLR7 ligation; however other viral TLR agonists 
failed to induce similar cytokine responses 
As we observed a decrease in secreted cytokine protein expression from BVDV-2 inoculated 
MDMΦs in response to bacterial TLRs, it would be interesting to explore TLRs specific to 
viral PAMPs.  Similarly as there is an increase in susceptibility to bacterial co-infection, 
BVDV infection in vivo does predispose an animal to secondary viral infection as well, and 
potentially a deficit in viral TLR responsiveness may contribute to this observation.  
Likewise, there have been no comparative studies of BVDV-2 strains and the effects of 
various viral TLRs in vitro.  Interestingly TNFα protein was not suppressed in BVDV-2 
inoculated MDMΦs in response to TLR7; however both TLR3 and TLR8 were suppressed in 
their responses (Fig. 5).  There were no statistically different levels of suppression among 
TNFα expression in either cytopathic 296c or non-cytopathic 296nc BVDV-2-inoculated 
MDMΦs (Fig. 5A).  Similarly, there were no differences in the amount of suppression of 
TNFα protein secretion between the MDMΦs inoculated with either HV 1373 or LV 28508 
(Fig. 5B) and stimulated with TLR agonists; however TLR7 agonists were able to induce a 
response in each of the viral infected groups, with each of them statistically similar to agonist 
stimulation alone. 
 Similar to findings with bacterial TLR agonists, cytopathogenicity or virulence does 
not effect the level of suppression on BVDV-2 inoculated MDMΦs stimulated with viral 
TLR agonists and in which TLR3 and TLR8 were both diminished in their ability to respond 
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in virally inoculated cells.  Likewise, IL-1β, IFNγ and IL-6 from virally inoculated cells with 
TLR3 and TL8 stimulation demonstrated a reduction in cytokine secretion (Supplemental Fig. 
1 & 2).  As our lab has found that MyD88 expression in vivo is modulated by BVDV-2 
infection, there was a similar reduction in expression of MyD88 from BVDV-2 inoculated 
MDMΦs, which corresponds to the reduced TLR responsiveness (Supplemental Fig. 3).  
However, there were no differences in gene expression of TLRs with viral inoculation, 
indicating that viral modifications of TLR responsiveness is not necessarily being modulated 
at the level of gene expression (not shown). 
 
BVDV-2 infected MDMΦs response to TLR7 involves phosphorylation of JNK 
Previous research has suggested that although TLR7 and TLR8 demonstrate overlap in 
function, they can play distinct roles in anti-viral responses.  TLR7 has been hypothesized to 
be JNK-dependent in its downstream signaling whereas TLR8 will be p38 MAPK-dependent.  
We investigated the aspect of JNK phosphorylation after TLR7 or TLR8 stimulation to 
elucidate the functionality of these TLRs in a BVDV-2 in vitro infection setting. TLR7 
stimulation after BVDV-2 inoculation induced phosphorylation of p46 and p54 JNK with a 
unique isoform observed at p46 as opposed to TLR8 stimulation (Fig. 6). In MDMΦs 
uninfected with BVDV-2 and with TLR7 stimulation (Fig. 6A), there was an induction and 
increase in phosphorylation of p54 and p46 JNK over time beginning at 10 min post TLR7 
stimulation and peaking at 120 min.  Similarly, uninfected cells with TLR8 stimulation also 
induced phosphorylation of p46 JNK, although the p54 isoform was not phosphorylated to 
the same extent (Fig. 6B).  Interestingly, the phosphorylation of p46 JNK after TLR8 
stimulation was greater than TLR7 stimulation in the uninfected MDMΦs (Fig. 6C).  After 
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BVDV-2 inoculation of 28508 and stimulation with TLR7 agonists, phosphorylation of p46 
and p54 JNK was induced and increased over time, similar to uninfected cells; however a 
unique isoform was observed at p46 (Fig. 6D).  After inoculation with 28508 and stimulation 
with TLR8 agonist, there was an induction of p46 JNK phosphorylation and there was no 
induction of p54 phosphorylation (Fig. 6E).  The isoform observed with TLR7 stimulation 
and BVDV-2 inoculation was not present in the TLR8 stimulated cells (Fig. 6D and E).  
Additionally phosphorylation of p46 from the BVDV-2 inoculated MDMΦs with TLR8 
stimulation was not as great at the TLR7 and BVDV-2 inoculated cells (Fig. 6F). 
 Likewise 296c- (Supplemental Fig. 4A-C), 296nc- (Supplemental Fig. 4D-F) or 1373- 
(Supplemental Fig. 4G-I) inoculated and TLR7 stimulated MDMΦs displayed similar 
phosphorylation and induction of a unique p46 isoform which was not observed with TLR8 
stimulation.  Thus, MDMΦs inoculated with BVDV-2 strains can respond to TLR7 ligation 
via phosphorylation of JNK p46 and p54 with a unique isoform present at p46, a 
phenomenon not observed with TLR8 ligation.  It is interesting to note that p38 MAPK 
phosphorylation was induced by 296c only, 296c with either TLR7 or TLR8 ligation, and 
with TLR8 ligation alone; however other viral strains did not induce p38 phosphorylation 
and did not with TLR ligation (not shown). 
 
DISCUSSION 
This study demonstrates that a Flaviviridae infection of MDMΦ induces robust 
proinflammatory cytokine mRNA responses, which are dependent on cytopathogenicity and 
virulence of the viral strains.  Conversely, there is no enhancement of TNFα, IL-1β, IFNγ or 
IL-6 protein secretion.  Importantly, response to secondary bacterial or viral TLR stimuli 
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after Flaviviridae infection is generally reduced compared to uninfected cells.  However, 
TLR7 signaling after BVDV infection is still intact; this response appears to be dependent on 
JNK phosphorylation. Furthermore, we observed phosphorylation of a unique isoform of p46 
JNK. 
Previous research has outlined some potential mechanisms of immune modulation in 
a BVDV infected host.  For instance decreased lymphocyte proliferation [26], decreased 
chemotaxis and inhibition of leukotriene formation in monocytes [27, 28], decreased 
microbicidal activity and random migration of neutrophils [29, 30], decreased expression of 
complement, Fc receptors and chemokine production of alveolar macrophages [31] each 
suggest a broad modulation within an infected host which can contribute to 
immunosupression.  Likewise, it has been suggested that monocytes or macrophage cells are 
critical in BVDV infection for disseminating virus [32, 33] and initiating apoptosis of T cells 
during infection [34, 35].  Interestingly, severe lymphopenia is observed in infected animals 
by means of an unknown mechanism; however monocytes are not reduced in the periphery [8, 
36, 37].  This suggests that monocytes or macrophages may play a critical role in recovery 
from BVDV infection, as they are not depleted throughout the course of infection. 
This is the first study to compare differences between isogenic or varying virulence 
strains of BVDV-2 and the impact on infected MDMΦ cytokine mRNA responses.  It is 
noteworthy that we saw a robust cytokine mRNA response, which was more pronounced in 
the cp and hv BVDV-2 strains (Fig. 1 & 2).  Of note, the work of others have demonstrated 
that TNFα mRNA transcription is enhanced in PBMCs infected with cp BVDV-1 strains, 
however comparison to non-cytopathic strains was not examined [38].  Similarly, persistently 
infected calves with either a cp or ncp BVDV-1 strain demonstrated enhanced TNFα 
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expression in cells isolated from the spleen  compared to uninfected calves [39]. TNFα 
expression can lead to the induction of apoptosis and it should be considered a potential 
mediating factor in the cytopathic effect induced in epithelial cells by cytopathic strains of 
BVDV [38].  This suggests that cp strains of BVDV-2 would indeed induce greater 
proinflammatory cytokine responses and concurs with our finding in expression of mRNA 
from infected MDMΦ.  Differences between induction of proinflammatory cytokines in 
MDMΦ infected with  high or low virulence strains of BVDV-2 has not been explored; 
however our finding suggest that hv strains of BVDV-2 induce a more robust mRNA 
response (Fig. 2).  Interestingly, this may correlate to disease severity as a greater amount of 
proinflamatory cytokines may be a contributing factor of host disease during BVDV 
infection [40] or severe Flaviviral infections in general [41-45], albeit we did not observe 
cytokine secretion.  Noteworthy is the observation that hvBVDV-2 strains 1373 induced 
proinflammatory cytokines begining at 6 h post inoculation as opposed to the MDMΦ 
response to the other strains which occurred beginning at 2 h post inoculation.  As this is the 
first published observations of MDMΦ responses in vitro to hv BVDV-2 strain 1373, is it 
possible that this particular strain of BVDV-2 is unique compared to the other strains we 
studied, as it is either not recognized as early by the MDMΦ to induce cytokine mRNA at 2h 
or is recognized by differing innate mechanisms. 
To date, expression of cytokine protein responses to BVDV-2 strains of varying 
virulence or isogenic cp/ncp strains have not been reported.  Surprisingly, although BVDV-2 
strains each induced cytokine mRNA, secreted protein was not significantly induced.  
However, the cytopathic 296c BVDV-2 strain did induce IL-6 which can help to induce 
apoptosis under certain conditions [46].  Similar to our finding, ncpBVDV-1 strains have 
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been shown to decrease intracellular protein expression of IL-1β and TNFα [47].  Not 
surprisingly, another Flaviviradae member, dengue virus demonstrated reduced expression 
of proinflammatory cytokines IL-1β, IL-8 and TNFα in whole blood from infected children; 
however this decrease in expression correlated to heightened clinical disease severity [48]. 
Overall, our research and the finding of others suggest that BVDV does limit cytokine 
protein secretion in infected cells. 
As such, we demonstrated a disconnect between mRNA expression and cytokine 
protein production in each of the BVDV-2 inoculated MDMΦ.  Previous studies have 
demonstrated a disassociation between mRNA expression and protein production [24, [49-
51].  However, some difference between mRNA expression and protein production may be 
related to cellular physiological functions as post-translational modification that inhibit 
protein production [52, 53], sequestering of protein which block secretion [54] or production 
of inactive forms of cytokines which require secondary mechanisms for activation and 
secretion [55].  Nonetheless, it should be noted that the dissociation between cytokine mRNA 
expression and protein secretion may be a trait of BVDV-2 pathogenesis. 
This is the only study to date in which cytokine responses of BVDV-2-infected 
MDMΦ to multiple TLR agonists have been explored.  However, a previous study has 
demonstrated that bone marrow derived macrophages (BMMΦ) infected with BVDV-1 in 
vitro have been shown to secrete less TNFα protein in response to LPS or bacterial infection 
compared to uninfected BMMΦs [25].  Similarly, TLR4 hyporesponsiveness has been 
demonstrated in MDMΦ from chronically infected HCV patients whereas this observation 
correlated to more severe disease and worse clinical outcome [56, 57]. Likewise, Flaviviral 
infections including yellow fever virus (YFV) or St. Louis encephalitis virus (SLEV), reduced 
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IL-1β levels in LPS-stimulated MDMΦ compared to uninfected control cells [58].  Similar to 
these findings, we demonstrated that varying TLR4 agonists as well as TLR2/1 agonists are 
diminished in their ability to promote pro-inflammatory cytokine secretion in MDMΦ after 
BVDV-2 infection.  Interestingly, each biotype suppressed MDMΦ cytokine secretion in 
response to bacterial TLR stimulation.   
As with bacterial TLR ligation, there is evidence that BVDV infection can decrease 
responsiveness to a double-stranded (ds)-RNA viral recognition receptor, TLR3 [47, 59].  
The dampened TLR3 response can be attributed to the BVDV ubiquination and degradation 
of interferon regulatory factor (IRF)-3 directly downstream of TLR3 activation by means of 
interaction with Npro protein of BVDV [60-62].  Thus, we demonstrated a reduction in viral 
TLR responsiveness in MDMΦ evidenced by a reduction in cytokine secretion by both TLR3 
and TLR8 stimulation after BVDV-2 infection (Fig. 5).  Intriguingly, TLR7 ligation was not 
dampened after BVDV-2 infection and was the only TLR tested that was statistically similar 
or enhanced in cytokine secretion compared to uninfected control cells. These findings along 
with the findings from this study of bacterial and viral TLR ligation (Fig. 4 & 5), demonstrate 
that there is a TLR hyporesponsivness induced by Flaviviradae including BVDV infection. 
MyD88 is an adapter protein essential for IL-1 receptor and various TLR signaling 
[63].  Research in our lab has demonstrated BVDV-2 in vivo infection can modulate MyD88 
expression in MΦ (manuscript under review) and as such we did observe a decrease in 
expression of MyD88 from infected MDMΦ (Supplemental Fig. 3).  However, MyD88 
expression was not completely ablated and some TLRs signal through complexes 
independent of MyD88 [64].  As such, viral means of manipulation of the TLR responses 
may not only be dependent on a reduction in MyD88 expression. 
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Furthermore, there have been no studies exploring JNK phosphorylation in response 
to BVDV-2 infection in MDMΦ.  This is the first to demonstrate a difference between TLR7 
or TLR8 stimulation and phosphorylation of p46 JNK isoforms in BVDV infected MDMΦ. 
TLR7 and TLR8 recognize similar viral components of single stranded (ss)-RNA and overlap 
in function.  However, differences between the two TLR pathways are beginning to be 
explored. TLR7 tends to strongly phosphorylate JNK [65, 66] whereas TLR8 will 
phosphorylate p38 MAPK to a greater extent [65, 66].  Likewise, plasmacytoid DCs and B 
cells preferentially signal through TLR7 [67] whereas monocytes signal through TLR8 [68]; 
although contain both TLRs.  TLR7 is believed to activate interferon regulatory factor (IRF) 
3,5 & 7 complexes and potentially mediate activation of cellular apoptosis [69, 70].  Recently, 
it is suggested that TLR7 may activate MyD88-independent pathways as some of these 
features of IRF activation as well as type-I interferon induction are homologous to TRIF 
signaling pathways [71]; however multiple studies have demonstrated reduced functionality 
of TLR7 with MyD88 knockout models [72-74].  Interestingly, JNK isoforms have been 
shown to be dependent on cell type although differences in functions of these isotypes are 
unknown [75-77].  Our study demonstrated that both TLR7 and TLR8 stimulation with 
BVDV infected did indeed induce phosphorylation of JNK 1/2 isoforms; although TLR7 
stimulation phosphorylated JNK to a greater extent (Fig. 6 & Supplemental Fig. 4).  
Surprisingly, TLR7 stimulation in BVDV-2 infected MDMΦ produced a unique isoform at 
p46 not observed with TLR8 stimulation or in uninfected cells. This is the first study in 
which this isoform was observed in cattle, and as TLR7 functionality was not decreased with 
BVDV-2 infection is may be that the isoforms observed at p46 may be contributing to the 
observed cytokine response. 
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Taken together, the findings in this study demonstrate that the BVDV-2 strains do 
vary in their induction of cytokine mRNA response from MDMΦ. Although a robust mRNA 
response was observed, protein secretion was not.  In addition, subsequent TLR stimulation 
of BVDV-2-infected MDMΦ resulted in a hyporesponsive cytokine response compared to 
uninfected MDMΦ.  However, TLR7 ligation induced cytokine responses in infected 
MDMΦ.  Furthuremore the cytokine response of TLR7 ligation involves JNK 
phosphorylation and phosphorylation of a unique p46 isoform.  Interestingly, MDMΦ 
infected with isogenic strains of cp/ncp BVDV-2 did not differ in suppression of TLR 
stimulated cytokine responses, indicating that NS2, NS3 or NS2/3 may not be an explanation 
of this observation; however IL-6 secretion may be mediated by NS2 or NS3.  These results 
demonstrate that BVDV-2 infection generally blocks TLR responsiveness and provide 
information on how this virus may contribute to susceptibility to secondary infection. 
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Figure 1. Expression of proinflammatory cytokine gene transcription in MDMΦs 
inoculated with cytopathic and non-cytopathic BVDV-2 strains.  MDMΦs were 
differentiated in 96 well plates for 7 days and inoculated with BVDV-2 strains in duplicate at 
an MOI of 1 with RNA harvested at 2, 6, 18, and 24 h after inoculation.  Cytokine mRNA 
was analyzed by qPCR using ribosomal protein s9 (RPS9) as an endogenous control with 
fold change expressed relative to uninfected control MDMΦs harvested at the corresponding 
time points. IL-1β (A), TNFα (B), IL-6 (C), IL-8 (D), IL-12p40 (E), IL-10 (F) were measured 
using primer sets specific for bovine genes using SYRB Green chemistry. Bars represent the 
mean value ± SEM from four different experiments from 9 different donor cattle. *** P < 
0.001; ** P < 0.005. 
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Figure 2. Expression of proinflammatory cytokine gene transcription in MDMΦs 
inoculated with high and low virulence BVDV-2 strains.  MDMΦs were differentiated in 
96 well plates for 7 days and inoculated with BVDV-2 strains in duplicate at an MOI of 1 
with RNA harvested at 2, 6, 18, and 24 h after inoculation.  Cytokine mRNA was analyzed 
by qPCR using ribosomal protein s9 (RPS9) as an endogenous control with fold change 
expressed relative to uninfected control MDMΦs harvested at the corresponding time points. 
IL-1β (A), TNFα (B), IL-6 (C), IL-8 (D), IL-12p40 (E), IL-10 (F) were measured using 
primer sets specific for bovine genes using SYRB Green chemistry. Bars represent the mean 
value ± SEM from four different experiments from 9 different donor cattle. *** P < 0.001. 
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Figure 3. Proinflammatory cytokine secretion of BVDV-2 inoculated or LPS stimulated 
MDMΦs 24 h after treatment. MDMΦs were differentiated in 96 well plates for 7 days and 
inoculated with BVDV-2 strains in duplicate at an MOI of 1 or 2ug/mL LPS with cell 
supernatants harvested at 24 h after treatment.  Cytokine protein was analyzed by Searchlight 
Array using analytes specific for bovine IFNγ (A), IL-1β (B), IL-6 (C) and TNFα (D) with 
50uL of cell supernatant analyzed in duplicate.  Cytokines were quantified by generation of 
standard curves against recombinant bovine cytokines provided by the manufacturer of the 
Searchlight platform. Bars represent the mean value ± SEM from four different experiments 
from 9 different donor cattle. ** P < 0.001. 
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Figure 4. TNFα protein secretion from BVDV-2 infected monocyte derived 
macrophages after stimulation with bacterial TLR agonists.  MDMΦs were differentiated 
in 96 well plates for 7 days and inoculated with BVDV-2 strains with an MOI of 1 for 48 h 
prior to stimulation with Pam3Cys [5µg/mL], M. haemolytica LPS [10µg/mL], or E. coli 
(055:B5) LPS [1µg/mL]. Cell supernatants were analyzed for TNFα protein concentration 24 
h after TLR stimulation and measured by Searchlight Array platform.  Incubation with 
cytopathic and noncytopathic strains are in the top panel (A) or high and low virulence 
strains indicated in the lower panel (B). Bars represent the mean value ± SEM from four 
different experiments from 9 different donor cattle. ** P < 0.001 compared to uninfected, 
TLR stimulated cells. 
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Figure 5. TNFα protein secretion from BVDV-2 infected MDMΦ after stimulation with 
viral TLR agonists.  MDMΦs were differentiated in 96 well plates for 7 days and inoculated 
with BVDV-2 strains with an MOI of 1 for 48 h prior to stimulation with Poly I:C [50µg/mL], 
Imiquimod [10µg/mL], ssRNA40 LyoVec [10µg/mL]. Cell supernatants were analyzed for 
TNFα protein concentration 24 h after TLR stimulation and measured by Searchlight Array 
platform.  Incubation with cytopathic and noncytopathic strains are in the top panel (A) or 
high and low virulence strains indicated in the lower panel (B). Bars represent the mean 
value ± SEM from four different experiments from 9 different donor cattle. ** P < 0.001 
compared to uninfected, TLR stimulated cells. 
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Figure 6. Kinetics of JNK phosphorylation in response to TLR7 or TLR8 stimulation of 
MDMΦ either with or without BVDV-2 infection. MDMΦs were differentiated in 96 well 
plates for 7 days and inoculated with BVDV-2 strains with an MOI of 1 for 48 h prior to 
stimulation with Imiquimod [10µg/mL] or ssRNA40 LyoVec [10µg/mL]. Cell lysates were 
analyzed for phosphorylated or total JNK through western blot after TLR stimulation at 10, 
20, 30 , 60 and 120 minutes.  Lysates from uninfected MDMΦ stimulated with TLR7 
agonists are in the top panel (A), stimulated with TLR8 agonists (B) and line graph 
representative of density ratio of phosphorylated:total JNK (C). Lysates from 28508 infected 
MDMΦ stimulated with TLR7 agonists are in the lower panels (D), stimulated with TLR8 
agonists (E) and line graph representative of density ratio of phosphorylated:total JNK (F). 
Line graphs represent the mean value from four different experiments from 9 different donor 
cattle. Lanes 1 (10 min), 2 (20 min), 3 (30 min), 4 (60 min), 5 (120 min) are lysates harvested 
after TLR stimulation. 
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Supplemental Figure 1. IL-1β, IL-6 and IFNγ protein expression in response to TLR 
stimulation in MDMΦ infected with BVDV-2 strains 296c or 296nc. MDMΦs were 
differentiated in 96 well plates for 7 days and inoculated with BVDV-2 strains with an MOI 
of 1 for 48 h prior to stimulation with Pam3Cys [5µg/mL], M. haemolytica LPS [10µg/mL], 
E. coli (055:B5) LPS [1µg/mL], Poly I:C [50µg/mL], Imiquimod [10µg/mL], or ssRNA40 
LyoVec [10µg/mL]. Cell supernatants were analyzed for protein concentration 24 h after 
TLR stimulation and measured by Searchlight Array platform.  Incubation with cytopathic 
and noncytopathic strains are indicated below each bar graph. Bars represent the mean value 
± SEM from four different experiments from 9 different donors. ** P < 0.001, * P < 0.05 
compared to uninfected, TLR stimulated cells. 
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Supplemental Figure 2. IL-1β, IL-6 and IFNγ protein expression in response to TLR 
stimulation in MDMΦ infected with BVDV-2 strains 1373 or 28508. MDMΦs were 
differentiated in 96 well plates for 7 days and inoculated with BVDV-2 strains with an MOI 
of 1 for 48 h prior to stimulation with Pam3Cys [5µg/mL], M. haemolytica LPS [10µg/mL], 
E. coli (055:B5) LPS [1µg/mL], Poly I:C [50µg/mL], Imiquimod [10µg/mL], or ssRNA40 
LyoVec [10µg/mL]. Cell supernatants were analyzed for protein concentration 24 h after 
TLR stimulation and measured by Searchlight Array platform.  Incubation with hv1373 or 
lv28508 strains are indicated below each bar graph. Bars represent the mean value ± SEM 
from four different experiments from 9 different donors. ** P < 0.001,  * P < 0.05 compared 
to uninfected, TLR stimulated cells. 
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Supplemental Figure 3. Expression of MyD88 in monocyte derived macrophages after 
24 h TLR stimulation and 2 day pre-incubation with BVDV-2 strains. Bacterial TLRs 
(A), viral TLRs (B), representative blot from 296c pre-incubation (C), representative blot 
from 296nc pre-incubation (D), representative blot from 1373 pre-incubation (E), 
representative blot from 28508 pre-incubation (F).  Treatments are represented in lanes 1 
(TLR 8), 2 (TLR 2/1), 3 (e. coli TLR 4), 4 (m. haemolytica TLR 4), 5 (TLR 3), 6 (TLR 7). 
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Supplemental Figure 4. Kinetics of JNK phosphorylation in response to TLR7 or TLR8 
stimulation in MDMΦ infected with BVDV-2. MDMΦs were differentiated in 96 well 
plates for 7 days and inoculated with BVDV-2 strains with an MOI of 1 for 48 h prior to 
stimulation with Imiquimod [10µg/mL] or ssRNA40 LyoVec [10µg/mL]. Cell lysates were 
analyzed for phosphorylated or total JNK through western blot after TLR stimulation at 10, 
20, 30, 60 and 120 minutes.  Lysates from 296c MDMΦ stimulated with TLR7 agonists are 
in the top panel (A), stimulated with TLR8 agonists (B) and line graph representative of 
density ratio of phosphorylated:total JNK (C). Lysates from 296nc infected MDMΦ 
stimulated with TLR7 agonists are in the middle panels (D), stimulated with TLR8 agonists 
(E) and line graph representative of density ratio of phosphorylated:total JNK (F). Lysates 
from 1373 infected MDMΦ stimulated with TLR7 agonists are in the lower panels (G), 
stimulated with TLR8 agonists (H) and line graph representative of density ratio of 
phosphorylated:total JNK (I).  Line graphs represent the mean value from four different 
experiments from 9 different donors. Lanes 1 (10 min), 2 (20 min), 3 (30 min), 4 (60 min), 5 
(120 min) are lysates harvested after TLR stimulation. 
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Abstract 
 
Macrophages are innate immune cells which can be important as antigen presenting cells 
(APCs) and are involved in the initiation of an adaptive immune response.  This is the first 
study to investigate function of monocyte derived macrophages (MDMΦ) infected with 
isogenic strains of cytopathic bovine viral diarrhea virus genotype 2 (BVDV-2) and strains of 
varying virulence in vivo and in vitro.  We isolated CD14+ cells from in vivo BVDV-2-
infected calves and performed transcriptional sequencing analysis in which changes in 
endocytic and phagocytic pathways were observed compared to cells from uninfected 
controls.  We recapitulated these findings in vitro and further demonstrated modulation of 
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MHC class II and CD80 cell surface expression.  Regardless of biotype, phagocytic capacity 
was diminished in BVDV2-infected MDMΦ.  Together these results demonstrate that 
MDMΦ are impaired in their ability to upregulate essential cell surface markers for antigen 
presentation as well as take up and present antigen.  These data support the evidence that 
BVDV-2 infection may alter antigen presentation capabilities of APCs that are critical for 
host responses to secondary infection. 
 
1.  Introduction 
 
Bovine viral diarrhea virus (BVDV) is a single stranded positive sense RNA virus in 
the Pestivirus genus which include classical swine fever virus and border disease virus.  
Pestiviral genomes are approximately 12.5kb in length and BVDV encodes for 11 or 12 
genes depending on cytopathogenicity and as such can be classified as cytopathic (cp) or 
non-cytopathic (ncp) (Bendfeldt et al., 2007).  BVDV is further categorized into genotypes of 
BVDV-1 and BVDV-2.  BVDV-2 strains can cause severe disease, which can be related to 
atypical or high virulence (hv) strains (Liebler-Tenorio et al., 2002) as opposed to typical or 
low virulence (lv) strains (Liebler-Tenorio et al., 2003) that cause mild or subclinical disease. 
 BVDV infection predisposes the host to secondary bacterial and viral infections and 
contributes to bovine respiratory disease complex (BRDC) in feedlot cattle (Confer, 2009).  
The immunosupression induced by BVDV infection is not fully understood, although 
changes in lymphocyte populations (Brewoo et al., 2007), modulation of cytokine secretion 
(Glew et al., 2003) and disruption in chemotaxis (Brown et al., 1991) may be factors of an 
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immune suppressed host.  However, study of varying virulence and isogenic 
cytopathic/noncytopathic biotypes of BVDV-2 strains on macrophage (MΦ) function has not 
been fully explored. 
 The MΦ is an important immune cell as it contributes to cytokine secretion in 
response to pathogenic challenge (Stow et al., 2009) and can present antigen to T cells to 
initiate an adaptive immune response (Unanue, 2002). To date, in vitro BVDV-1 infection 
has been shown to downregulate TNFα expression, modulate fluid uptake and endocytic 
pathways and decrease Fc receptor expression in MΦ (Boyd et al., 2004; Lee et al., 2008; Liu 
et al., 1999; Welsh and Adair, 1995); however the impacts of BVDV-2 on MΦ function is 
unknown.  In this study we characterized changes of antigen presentation pathways in an in 
vivo BVDV-2 infection and recapitulated results in vitro. 
 
2. Materials and Methods 
 
2.1. In vivo experimental procedures and viral inoculum 
 
 Eighteen clinically healthy, colostrum-deprived Holstein calves were used in two 
experiments.  Calves were negative for BVDV and antibodies to BVDV as determined by 
virus isolation from buffy coat followed by polymerase chain reaction (PCR) and serum 
neutralization using BVDV 1 strain NY-1 and BVDV 2 strain 1373. Experimental infections, 
run in duplicate, were conducted under BL2 containment. Calves were group housed by 
experimental group. Two- to five- week old calves were inoculated intranasally with 5mL of 
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105-6 TCID50 of BVDV-2 strain 1373 (n=3/replicate) or RS886 (n=3/replicate). Additional 
calves (n=3/experiment) were mock inoculated and served as age-matched negative controls. 
Clinical signs were monitored twice per day. Blood samples were collected in anticoagulant 
tubes on days 5 and 14 post inoculation.  Numbers of leukocytes and platelets were 
determined for each animal. Buffy coat was examined for BVDV by viral isolation and PCR 
for confirmation of infection. Animal procedures employed in these studies were approved 
by the National Animal Disease Center Institutional Animal Care and Use Committee. 
 
2.2. RNAseq 
 
 RNAseq sample preparation and analysis was performed as previously described 
(Ridpath et al., 2012).  Briefly, buffy coats were isolated at days 5 or 14 post BVDV 
inoculation.  Buffy coats were sorted by magnetic separation using MiniMACS columns 
(Miltenyi Biotec, Auburn, CA) for T cells (CD3+), B cells (IgM+), or monocytes (CD14+) 
and lysed for RNA extraction. Samples were prepared using the TruSeq RNA sample prep 
kit v1 (Illumina, San Diego, CA).  Clusters were generated using the cBot and TruSeq 
Cluster generation kits with sequencing performed on a HiSeq 2000 instrument using 50 
Cycle Single Read approach with Tru Seq SBS v2 chemistries (Illumina). 
 
2.3. In vitro experimental procedures, viral inoculum and MΦ isolation 
 
 12 clinically healthy Holsteins of approximately 1-2 years of age were used for blood 
donors.  Animals were negative for BVDV as measured by an immunohistochemistry (IHC) 
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positive ear notch. Peripheral blood mononuclear cells were isolated and red blood cells 
(RBC) lysed with buffered ammonium chloride salt solution.  After RBC lysis, cells were 
washed with sterile phosphate-buffered saline (PBS).  Cells were resuspended in complete 
RPMI 1640 (cRPMI) containing 10% fetal bovine serum (tested free of BVDV and 
antibodies against BVDV), 2mM L-glutamine, 1% antibiotic–antimycotic solution, and 
gentamicin sulfate (Gibco, Carlsbad, CA).  Monocytes were isolated by plastic adherance.  
Ice-cold PBS was added to the plate and adherent cells were removed with a cell scraper.  
Cells were centrifuged at 1180 x g (Sorvall RC3C Plus, Thermo Scientific, Waltham, MA), 
and resuspended in cRPMI 1640 at 5x106 cells per mL.  Monocytes were plated in 96-well 
round bottom tissue culture plates in 100 µL medium. Monocytes were cultured for 7 days 
with media change every 2-3 days to derive MΦ. Cells isolated from animals were tested for 
BVDV through reverse transcription (RT)-PCR with primers selective for BVDV genotypes 
1a, 1b, and 2 and were negative prior to experimentation. BVDV-2 strains were propagated 
in MDBK cells with a viral titre determined by histological staining as follows: 296c [TCID50 
6.8x106], 296nc [TCID50 3.8x108], 1373 [TCID50 6.22x106], 28508 [TCID50 2.37x106].  Cells 
were inoculated with an MOI of 1. 
 
2.4. qPCR 
 
 At 2, 6, 18, and 24 h post BVDV inoculation, cells were lysed with Buffer RLT 
containing 2-mercaptoethanol (Qiagen, Valencia, CA) and stored at −80°C. Total RNA was 
isolated using the RNeasy Mini RNA Isolation Kit (Qiagen) and genomic DNA was removed 
during RNA isolation using an on-column RNase-Free DNase I digestion set (Qiagen) per to 
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manufacturer’s instructions. 500 ng of total RNA from each sample was reverse transcribed 
using random primers/hexamers and Superscript III (Invitrogen) to generate first strand 
cDNA. Primers were designed specifically for SYBR Green chemistry with the use of Primer 
Express v 3.0 (Applied Biosystems, Foster City, CA) or NCBI Primer Blast.  Primer 
annealing temperature was set at 60°C with product size of 100-200 base pairs. Bovine 
ribosomal protein S9 (RPS9) (Nelson et al., 2010) was used as the endogenous control. 
Primer set sequences are indicated in Table 1. An Applied Biosystems 7300 Real Time PCR 
Systems thermocycler was used.  Amplification conditions for all genes were the same: 2 
min at 50°C, 10 min at 95°C, 40 cycles of 15 s 95°C and 1 min 60°C (measure florescence 
step) and a dissociation step of 15 s 95°C, 1 min 60°C, 15 s 95°C, 15 s 60°C. Ct values were 
calculated and normalized to the endogenous control and expressed relative to medium only 
treatment using the 2-ΔΔCT method (Livak and Schmittgen, 2001). 
 
2.5. Flow cytometry 
 
 Cells were inoculated with BVDV-2 strains for 24h prior to staining for cell surface 
marker expression.  Cells were blocked with goat serum and anti-FcγRI/III antobodies. MHC 
class I, MHC class II, CD14, CD80 were used at 1µg/µL concentrations with secondaries of 
0.5 µg/µL. 
 
2.6. Phagocytosis assays 
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 Cells were inoculated with BVDV-2 strains at an MOI of 1 and allowed to incubate 
for 24 h prior to phagosome assays.  Procedures for assays have been described previously 
(Savina et al., 2010). Briefly, amine-based latex beads were coated with FITC or Fluoprobe-
678 for measurement of pH.  Cells were allowed to phagocytose beads and samples collected 
at 10, 20, 30, 60, 120 and 180 min after phagocytosis.  Amine-based latex beads were coated 
with Rhodamine or Fluoprobe-678 for oxidation assays.  Cells were allowed to phagocytose 
beads and samples collected at 10, 60 and 120 minutes.  Live cells were gated and cells 
which had phagocytosed beads were measured. 
 
2.7. Statistical analysis 
 
qPCR cytokine data was analyzed with the outcome variable (2-ΔΔCT) log transformed. 
ΔΔCt values were analyzed using one-way ANOVA (Prism, GraphPad, LaJolla, CA). 
Bonferroni post test was used to compare replicate means by row to uninfected controls. 
Flow cytometry data was analyzed using one-way ANOVA (Prism, GraphPad) with 
Bonferroni’s multiple comparison test was used to compare replicate means by row to all 
columns.   Results are expressed as means +/- standard errors of the means (SEM). 
 
3. Results 
 
3.1. RNAseq analysis of CD14+ cells isolated from an in vivo infection with a high- or low-
virulence BVDV-2 strain 
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 To understand potential mechanisms of immune-modulation that may occur during 
BVDV-2 infection, deep sequencing analysis of CD14+ monocytes isolated from calves early 
in infection (day 3) and late (day 15) was performed. A total of 1033 genes was significantly 
different compared to uninfected CD14+ cells at day 3 post infection with a total of 1237 
gene differentially expressed at day 15.  Interestingly, when comparing the monocytes 
isolated from infected calves compared to cells isolated from uninfected animals differences 
in regulation of pathways involving phagocytosis, antigen processing, endocytosis and 
ubiquitin mediated proteolysis was impacted and these pathways were selected for further 
analysis (Table 2). Within these pathways, at day 3 post BVDV2 infection, there was an 
increase in gene expression of antigen peptide transporter 1, myristoylated alanine-rich 
protein kinase C and ubquitin conjugating enzyme E2L6.  These genes are important in the 
internalization, rearrangement of the cytoskeleton and proteolytic degradation of proteins. 
Conversely, at day 3 there was a decrease in gene expression of lysosomal lipase A, dynamin 
1 and fragment crystalizable IgA receptor (FcαR).  However, by day 15, only ubquitin-like 
modifier activating protein enzyme 7 was increased, whereas macrophage receptor with 
collagenous structure (MARCO) and syntaxin 3 was decreased.  Thus, as BVDV-1 can 
modulate endocytic pathways in vitro (Boyd et al., 2004), taken together with this data from 
in vivo BVDV-2 infection suggests that BVDV modulates the transcriptional pathways 
involved in the ability of MΦ to engulf and process antigens. 
 
3.2. qPCR analysis of cell surface molecules related to antigen presentation 
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 As phagocytic and antigen processing pathways were impacted in vivo, it is possible 
that surface molecule expression related to antigen presentation may be modulated at the 
transcriptional level.  Cells were infected with varying strains of BVDV-2 and RNA was 
isolated at 2, 6, 18 and 24 h post inoculation.  MHC class I expression in MDMΦ (Fig. 1A) 
was reduced at 2 h post 1373 and 28508 BVDV-2 inoculation compared to uninfected 
controls; however there was no significant changes in expression in any other timepoint or 
treatment groups. MHC class II (Fig. 1B) was reduced in expression from virally infected 
MDMΦ compared to controls at 24 h post 296c BVDV inoculation, as well as 2h post 1373 
and 28508 BVDV-2 treatment. Conversely, CD80 (Fig. 1C) was heightened in expression 
from 296c infected MDMΦ response to at 2, 6, 18 and 24 h as well as MDMΦ infected with 
296nc at 18 and 24 h after inoculation.  1373 and 28508 inoculated MDMΦ demonstrated 
increase mRNA expression of CD80 at 6, 18 and 24 h compared to expression from 
uninfected MDMΦ.  CD86 (Fig. 1D) was not significantly up or down regulated after any 
viral treatment.   Likewise it has been demonstrated that ncp or cpBVDV-1 can modulate 
CD80 or CD86 mRNA expression (Lee et al., 2008) in vitro and taken with these data 
suggest that BVDV-2 infection modulates mRNA expression of some cell surface markers. 
 
3.3. Mean fluorescent intensity of cell surface marker expression as determined by flow 
cytometry 
 
 To develop a better understanding of the effects of BVDV on the cell surface marker 
expression, we used flow cytometry to measure expression of MHC class I, MHC class II 
and CD80 (Fig. 2).  Interestingly, there was a significant decrease in expression of MHC 
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class II on the MDMΦ infected with BVDV-2 strains and stimulated with LPS compared to 
uninfected LPS-stimulated only. Likewise, there was a significant decrease in MFI 
expression between MDMΦ infected with BVDV2 strains and BVDV2 with LPS stimulation, 
indicating that BVDV2 can downregulate surface marker expression in response to LPS.  
Similarly, CD80 demonstrated similar findings to MHC class II surface expression. However, 
MHC class I was up regulated in some infected cells (Fig 2A).  Overall, there was a 
significant decrease in expression of cell surface markers in response to LPS in BVDV2 
infected MDMΦ  (Fig. 2B). 
 
3.4. Mean fluorescent intensity of pH sensitive FITC-labeled amino-latex beads as 
determined by flow cytometry 
 
 To determine if BVDV-2 infection would decrease the acidification processing of the 
phagosome, pH sensitive FITC-labeled beads were internalized by infected MDMΦ.  Over a 
timecourse, the intensity of FITC was measured to allow for a determination in acidification 
and neutralization of the phagosome by gating on single bead internalized populations (Fig. 
3A).  However, there was no statistical difference in acidification, and the MDMΦ were able 
to acidify the phagosome in response to LPS (Fig. 3B). 
 
3.5. Mean fluorescent intensity of reactive oxygen species-sensitive Rhodamine-labeled 
amino-latex beads as determined by flow cytometry 
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To determine if BVDV-2 infection would decrease the oxidative capacity of the 
phagosome, reactive oxygen species (ROS) sensitive rhodamine-PE-labeled beads were 
internalized by infected MDMΦ.  Over a timecourse, the intensity of PE was measured to 
allow for a determination in oxidation of the bead by gating on single bead internalized 
populations.  However, there was no statistical difference in oxidation, and the MDMΦ were 
able to oxidize the phagosome as well as in response to LPS (Fig. 4). 
 
3.6. Analysis of phagocytic capacity as determined by flow cytometry 
 
 To determine if BVDV-2 infection of MDMΦ would alter the ability of the cells to 
internalize particles, infected MDMΦ were incubated with latex-amino-beads.  The cells 
were then analyzed for percent positive or negative for internalized bead (Fig. 3A).  
Interestingly, BVDV-2 infection did decrease the ability of the cells to uptake beads.  The 
296c and 28508 infected MDMΦ demonstrated the greatest impact on phagocytosis; however 
each of the virally treated groups demonstrated a statistical decrease in phagocytic capacity 
(Fig. 5). To observe if LPS activation could recover any loss in phagocytic capacity, cells 
were stimulated with LPS prior to internalization of beads.  Only 296nc-infected MDMΦ 
demonstrated recovery and were statistically similar to uninfected cells (Fig. 5 – right panels). 
 
4. Discussion 
 
 Previous in vitro studies have explored transcriptional changes that may occur during 
infection with BVDV.  For instance, MDBK cells infected in vitro with BVDV-2 strain 1373 
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demonstrated decreases in expression of α-Tubulin and β-Tubulin as well as genes associated 
with glycolysis, electron transport, ATP metabolism and elongation factors (Neill and 
Ridpath, 2003).  These data suggest that BVDV-2 potentially modulates protein packaging 
and internaliztion or endocytosis mediated by tubulin molecules (Popova and Rasenick, 
2004).  Similarily bovine monocytes infected in vitro with BVDV-1 ncp strains NADL 
demonstrated a decrease in expression of MHC class I and MHC class II (Lee et al., 2009) 
which suggest a potential impairment in antigen presentation. As such, we decided to 
investigate the effects of BVDV-2 on CD14+ monocytes isolated from the blood from in vivo 
infected animals.  Interestingly, we identified an early (day 3) increase in transcription of 
antigen presentation-associated genes; although endosomal associated genes were decreased 
in expression.  This was sustained late in infection (day 15) in which we observed a decrease 
in expresion of macrophage receptor with collagenous structure (MARCO), a non-specific 
receptor of endocytosis and phagocytosis. Taken together, these data suggest that BVDV 
infection may modulate endocytic or phagocytic pathways of MDMΦ. 
 Findings have suggested that monocytes infected with BVDV-1 strains are 
compromised in their gene expression of CD80, CD86, MHC class I and MHC class II (Lee 
et al., 2008).  As there have been no comparative studies on the effects of BVDV-2 infection 
on expression of associated antigen presentation molecules in MDMΦ, we investigated the 
effects of viral infection to modulate cell surface marker gene expression.  Interestingly, we 
did not observe a sustained decrease in expression of any of the molecules examined; 
however MHC class I expression in MDMΦ infected with 1373 and 28508 strains was 
reduced early in infection.  Similarly MHC class II was reduced in MDMΦ infected with 
1373 and 28508 early in infection. As our results are contrary to BVDV-1 studies, it is 
	   153	  
possible that mechanisms of suppression in antigen presentation may differ between BVDV-
2 genotypes. Infection of plasmacytoid dendritic cells with Dengue virus, a related 
Flaviviradae species, induces enhanced expression of CD80, CD86, and CD40; in turn, 
promote an enhanced TNFα and IFNα/β response potentially contributing to pathological 
outcome (Sun et al., 2009). However, BVDV-2 infection of MDMΦ may not necessarily be 
modulating antigen-presenting capabilities at the transcriptional level as there were no 
sustained significant reductions in expression of cell surface molecules associated with 
antigen presentation. 
 A previous study of BVDV-1 infection in monocytes or dendritic cells demonstrated 
only minimal differences in MFI of MHC class I, MHC class II, CD80 and CD86 between 
infected and mock treated cells.  However, the authors demonstrated a deficiency in allogenic 
and ova specific induced responses of monocytes to induce T cell proliferation (Glew et al., 
2003).  Interestingly, an earlier study demonstrated that PBMCs isolated from persistently 
infected (PI) BVDV calves were able to induce a robust allogenic T cell response (Glew and 
Howard, 2001).  As such, we demonstrated that varying genotypes of BVDV-2 infected and 
LPS stimulated MDMΦ have reduced expression of MHC class II and CD80 compared to 
LPS-only treated MDMΦ. Our studies suggest that there may be a decrease in the ability of 
BVDV-2 infected MDMΦ to drive T cell proliferation. 
 It is possible that a deficit in phagosomal function may contribute to the reduced 
antigen-presentation capabilities of BVDV-infected MDMΦ.  Interestingly, alveolar 
macrophages from BVDV and BRSV infected cattle demonstrated a decrease in Fc receptor 
expression, phagosome-lysosome fusion and superoxide anion production (Liu et al., 1999). 
As phagosomal fusion is disrupted, is may be possible that pH is also impaired.  However, 
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we found no differences in phagosome acidification between infected and uninfected MDMΦ 
with of with LPS treatment.  Likewise, we observed no alterations in oxidative capacities of 
the phagosome between infected and non-infected groups. Thus our data suggests there are 
no modifications in acidification or oxidation in BVDV2-infected MDMΦ. 
 Previous studies have demonstrated that monocytes infected with BVDV strains have 
decreased expression of genes associated with Fc-mediated phagocytosis (Ammari et al., 
2010; Pinchuk et al., 2008). Similarly, it has been demonstrated that monocytes infected with 
BVDV-1 strains have reduced mannose receptor-mediated endocytosis, macropinocytosis, or 
caveolae-mediated antigen uptake (Boyd et al., 2004).  Likewise, alveolar macrophages 
isolated from BVDV infected calves and restimulated with BVDV demonstrated an impaired 
ability to phagocytose yeast particles (Welsh and Adair, 1995).  Interestingly, we 
demonstrated cytopathic, noncytopathic, high or low virulence BVDV-2 infected MDMΦ 
supressed the ability to phagocytose amine-latex-beads.  In summary, our data and the data 
from others suggest BVDV-2 infection does impair phagocytosis function of antigen 
presentating cells. 
 Endocytosis and phagocytosis are important mediators in antigen internalization and 
processing.  Equally critical are cell surface molecules required to interact with adaptive 
immune cells to promote lasting immunity.  Changes in these cellular processes during 
infection may lead to a diminished immune response or potentially modulate disease 
progression.  We have shown that BVDV-2 infected MDMΦ display a modulated cell 
surface expression of antigen presentation molecules.  However, BVDV-2 infection of 
MDMΦ does not modulate acidification or oxidative capacity of the phagosome; although 
phagocytosis is impaired compared to uninfected cells.  These changes in macrophage 
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antigen uptake and presentation may contribute to increased susceptibility to secondary 
infections.  
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Figure 1. Expression of cell surface markers in MDMΦ after stimulation with BVDV-2 
strains.  MDMΦσ were differentiated in 96 well plates for 7 days and inoculated with 
BVDV-2 strains in duplicate at an MOI of 1 with RNA harvested at 2, 6, 18, and 24 h after 
inoculation.  Cytokine mRNA was analyzed by qPCR using ribosomal protein s9 (RPS9) as 
an endogenous control with fold change expressed relative to uninfected control MDMΦs 
harvested at the corresponding time points. MHC class I (A), MHC class II (B), CD80 (C), 
CD86 (D) were measured using primer sets specific for bovine genes using SYRB Green 
chemistry. Bars represent the mean value ± SEM from four different experiments from 9 
different donors. ** P < 0.05. 
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Figure 2. MFI of cell surface antigens expression on MDMΦ as measured by flow cytometic 
analysis.  MDMΦ were incubated for 7 days in culture, prior to BVDV-2 inoculation of an 
MOI of I.  Virally treated cells were incubated for 48 h prior to LPS stimulation.  Histograms 
represent isotype controls (solid red), BVDV-2 + LPS treated MDMΦ (blue) and LPS only 
(solid green).  Bar graphs represent SEM of ΔMFI (Treatment group MFI – isotype control 
MFI) from 6 different animals from 3 independent experiments. * P < 0.1. 
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Figure 3. Flow cytometric analysis of phagosome acidification in virally infected or 
uninfected MDMΦ. MDMΦ were incubated for 7 days in culture, prior to BVDV-2 
inoculation of an MOI of I.  Virally treated cells were incubated for 48 h prior to LPS 
stimulation. Bead MFI was measured at 10, 20, 30, 60, 120 minutes post internalization. 
Cells were gated on one bead internalized (A) for pH analysis, and excluded cells which had 
not phagocytosed bead. Bar graphs represent MFI of viral or mock-infected treatment groups 
with or without LPS stimulation. pH standard curve was generated with known pH values for 
determination of MFI to pH ratio. Bar graphs represent SEM from 9 total animals from 3 
independent experiments. 
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Figure 4. Flow cytometric analysis of phagosome oxidation in virally infected or uninfected 
MDMΦ. MDMΦ were incubated for 7 days in culture, prior to BVDV-2 inoculation of an 
MOI of I.  Virally treated cells were incubated for 48 h prior to LPS stimulation. Bead MFI 
was measured at 60 minutes post internalization. Cells were gated on one bead internalized 
for ROS analysis, and excluded cells which had not phagocytosed bead. Bar graphs represent 
SEM of MFI of viral or mock-infected treatment groups with or without LPS stimulation 
from 9 total animals from 3 independent experiments. 
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Figure 5. Flow cytometric analysis of phagocytic capacity in virally infected or uninfected 
MDMΦ. MDMΦ were incubated for 7 days in culture, prior to BVDV-2 inoculation of an 
MOI of I. Cells were allowed to internalize amino-latex beads and were analyzed for percent 
positive or negative internalization. Bar graphs represent SEM from a total of 9 animals and 
three independent experiments. Bar graphs represent SEM 9 total animals from 3 
independent experiments.  ** P < 0.05  
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CHAPTER FIVE. GENERAL CONCLUSIONS 
 
 BVDV has a major annual economic impact on cattle, either through acute disease or 
susceptibility to secondary infection (11, 12). To date, vaccines are available although 
problems of efficacy, usage and cost are limiting factors.  As BVDV is immunosupressive, it 
contributes to BRDC in feedlot cattle predisposing the animals to a multitude of bacterial and 
viral pathogens (6, 7). There is a need to understand the underlying mechanism of viral 
suppression for developing treatment and helping to potentiate better vaccines.  Given that 
monocytes are not depleted during in vivo infection with BVDV (2, 3, 9, 10), they may be an 
important cell in the recovery of infection.  Interestingly, during in vivo BVDV-2 infection 
monocytes are hyperresponsive to LPS stimulation.  This hypersensitivity may be 
contributory to increased levels of proinflammatory cytokines in circulation.  This increase in 
inflammatory cytokine can contribute to induced apoptosis of peripheral blood cells as well 
as increased severity of disease (8, 13).  Interestingly, we demonstrated that monocytes from 
infected calves that were differentiated into MDMΦ demonstrated hyporesponsive TLR4 
cytokine secretion.  Interestingly, this can be contributory to an increase in susceptability to 
secondary infection, as TLR4 is criticial in the sensing of bacterial LPS.  When examining a 
tissue derived macrophage, the AMΦ, it was found that these cells isolated from infected 
calves are hyperresponsive to LPS in mRNA expression of IL-1β and TNFα; however 
conversely are reduced in expression and secretion of IL-6 compared to cells from uninfected 
animals.  Taken together, these results suggest that myeloid lineage cells isolated from 
BVDV-2 infected calves are modulated in their TLR4 response; and potentially maturation 
state of these cells impact the viral effects on function.  A mechanisms of reduction in 
cytokine expression and secretion is explained by the reduction in MyD88 and IKKβ 
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phosphorylation.  We demonstrated that BVDV NS5A interacts with MyD88, although the 
effect of that interaction is unknown.  Secondly, we determined that in vitro inoculation with 
varying strains of BVDV decreased TLR responsiveness across a multitude of TLRs.  
Interestingly, we found that TLR7 is responsive which may be explained by JNK 
phosphorylation and identification of a unique isoform of p46 JNK.  Thirdly, we determined 
that the antigen presentation capability of BVDV-2 infected MDMΦ may be due to a 
decrease in expression of cell surface markers MHC class II and CD80 as well as a dramatic 
decrease in phagocytic capabilities.  Taken together these studies provide information on the 
effects of BVDV-2 infection as well as identifying some potential aspects of underlying 
immunosupression which can lead to secondary infection. 
Specific Aim 1. These studies determined the effects of an in vivo infection of hv and lv 
BVDV-2 strains on myeloid cells isolated from infected calves.  Although hv infected calves 
display severe acute disease whereas lv infection is sub-clinical acute, both strains 
demonstrated immunomodulation of myeloid cells isolated from infected calves. 
2-6 week old colostrum-deprived calves, which were negative for BVDV and BVDV 
antibodies, were utilized for these studies.  Monocytes were isolated throughout the course of 
infection and analyzed for pro-inflammatory cytokine transcription and secretion.  As well, 
MDMΦ were generated as well as AMΦ harvested at necropsy.  Interestingly, monocytes 
isolated from BVDV-2 infected calves were increased in mRNA transcription for 
proinflammatory cytokines and demonstrated a hyperresponse to LPS stimulation.  
Conversely, MDMΦ isolated from BVDV-2 infected calves were hyporesponsive to LPS 
compared to cells isolated from uninfected calves.  AMΦ enhanced IL-1β and TNFα mRNA 
expression; although IL-6 transcription and secretion was reduced compared to AMΦ from 
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control calves.  Thus, MyD88 and IKKβ phosphorylation was decreased in cells isolated 
from infected calves, which may be a contributing factor of observed modulation in 
cytokines.  Interestingly, we demonstrated that BVDV NS5A and MyD88 co-localize. Yet, 
the effect of this interaction is unknown although may be similar to the observed interaction 
demonstrated between HCV NS5A and MyD88 (1). 
Specific Aim 2. These studies determined the effects of multiple biotypes of BVDV-2 strains 
on MDMΦ cytokine transcription and secretion.  Additionally, TLR responsiveness was 
observed as well as downstream signaling molecule JNK.  Interestingly, all BVDV-2 strains 
demonstrated an effect on MDMΦ by which cytokine response was reduced. 
 Approximately 1-year-old BVDV/BVDV antibody free cattle were used as blood 
donors for MDMΦ isolation and generation. These cells were inoculated with BVDV-2 
strains and mRNA expression of pro-inflammatory cytokines was determined.  Of note, a 
robust pro-inflammatory mRNA response was observed, although the cp and hv BVDV-2 
strain induced the greatest levels of mRNA expression in the MDMΦ.  Interestingly, protein 
was not secreted by the infected MDMΦ in response to BVDV-2 infection.  The TLR 
response MDMΦ after BVDV-2 inoculation was diminished for TLR2/1, TLR4, TLR 3 and 
TLR8 stimulation compared to uninfected control cells.  Indeed, TLR7 was responsive which 
was attributed to JNK phosphorylation and an observed isoform at p46.  In summary, these 
results suggest that BVDV-2 infection will decrease the responsiveness to a multitude of 
TLRs, which can contribute to secondary infection. 
Specific Aim 3. These studies determined the effects of BVDV-2 infection in vivo and in 
vitro on the antigen processing and presentation abilities of CD14+ or MDMΦ cells. 
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2-6 week old colostrum-deprived calves, which were negative for BVDV and BVDV 
antibodies, were utilized for the in vivo studies; whereas approximately 1-year-old 
BVDV/BVDV antibody free cattle were used as blood donors for MDMΦ isolation and 
generation. In vivo transcription of endocytic and phagocytic pathways were decreased in 
CD14+ cells isolated from infected animals compared to uninfected controls.  Moreover, in 
vitro qPCR analysis suggest that BVDV-2 infected MDMΦ may slightly decrease MHC 
class I or MHC class II expression; although this observation is not sustained throughout the 
time course analyzed.  When analyzing cell surface marker expression of MHC class II and 
CD80 by flow cytometry, MFI was decreased in BVDV-2 infected MDMΦ stimulated with 
LPS compared to LPS only treated cells.  Likewise, phagocytic capability of these BVDV-2 
infected cells was decreased compared to uninfected controls, although acidification and 
oxidation of the phagosome was not effected. 
Taken together, these data reported in this dissertation studies support the 
immunesuppression observed in MDMΦ from BVDV infection in vivo or in vitro by a 
decrease in: expression of pro-inflammatory cytokines, reduction in expression of MyD88, a 
decrease in phosphorylation of IKKβ, hyporesponsive TLRs, decreased expression of antigen 
presentation associated molecules and reduction in phagocytic capabilities. Evidence 
suggests that BVDV contributes to secondary bacterial and viral infection (4, 6, 7) and as 
such, mediating factors in these infections may be the observed functional changes induced 
by BVDV infection of immune cells. This dissertation has demonstrated that a functionally 
deficit MDMΦ may be a contributing factor of BVDV disease and lasting immune 
suppression. 
 
	   174	  
Recommendations for Future Work 
 The goal of this dissertation is to examine the changes induced by BVDV on the 
innate immune cells of the host.  In vivo we were able to examine AMΦ at time of necropsy, 
however, this timepoint may not represent all of the changes which may have occurred 
during infection.  As AMΦ are first responders to infection and would be one of the initial 
immune cells to initate a response to BVDV infection, it would be interesting to examine the 
early response. Interestingly, within 24 hours after infection, changes within the peripheral 
blood leukocyte population occured, which may indicate a cellular infiltration into the tissue 
such as the lung. As well, a timecourse by which AMΦ could be harvested throughout 
infection would be interesting to examine any functional changes which may occur. 
 As AMΦ are only one type of tissue MΦ, other MΦ such as splenic MΦ, peritoneal 
MΦ, or kupffer cells would be interesting to investigate cytokine responses as a comparison.  
We demonstrated that monocytes and terminally differentiated cells isolated from infected 
calves do indeed function differently, and potentially MΦ populations may as well. Likewise, 
in vitro derived BMMΦ may be another interesting cell as the bone marrow during BVDV 
infected undergoes dramatic change. 
 Although we conducted experiments to analyze cell surface markers of monocytes 
during in vivo BVDV infection, we were unable to determine changes in MHC class I, MHC 
class II, CD80, Fas or other potentially important maturation and effector molecules.  Most 
likely, the blood we were able to collect and subsequent cells isolated was extremely limited, 
and future work could be planned to only harvest blood for flow analysis.  Likewise, study of 
isolated monocytes and derived MΦ or DCs to stimulate an allogenic response may be 
another intersting aspect of BVDV induced modulation of function.   
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 As we determined an interaction between NS5A and MyD88, it would be interesting 
to further characterize this interaction.  By insering point mutations within the NS5A 
sequence, we can modify the structure of this protein.  In vitro analysis will allow us to 
determine potential binding regions and protein motifs which may be ciritical for NS5A-
MyD88 interaction. Furthemore, it would be interesting to produce transgenic MyD88 
knockout cell lines, such as with MDBKs, and observe potential changes this may have on 
viral propagation or cytokine response.  As NS5A has been shown to be important in viral 
replication, sequencing analysis between virulence biotypes may provide further insight into 
how genetic differences of the NS5A gene could impact virulence. If localizd regions in the 
NS5A gene demonstrate great genetic variability between strains, we could target those 
regions for mutagenesis and see if they are a critical aspect of virulence. 
 In vitro we found that TLR7 stimulation after BVDV-2 infection is still functional.  
Although we attributed this to cytokine expression in MDMΦ, JNK phosphorylation can lead 
to apoptosis.  It is possible, certain cell types which express TLR7, may induce apoptosis in 
response to BVDV. For instance, lung epithelial cells have been demonstrated to express 
TLR7 (5), and as BVDV would interact with this cell type, TLR7 induction of apoptosis may 
play a role in disease.  As we found TLR7 to be JNK mediated in response to BVDV, using 
JNK inhibitors can be used to confirm this aspect of  the response. 
 
References 
1. Abe, T., Y. Kaname, I. Hamamoto, Y. Tsuda, X. Wen, S. Taguwa, K. Moriishi, O. 
Takeuchi, T. Kawai, T. Kanto, N. Hayashi, S. Akira, and Y. Matsuura. 2007. 
Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-
dependent signaling pathway in macrophage cell lines. J. Virol. 81:8953-8966. 
	   176	  
2. Brewoo, J. N., C. J. Haase, P. Sharp, and R. D. Schultz. 2007. Leukocyte profile of 
cattle persistently infected with bovine viral diarrhea virus. Vet. Immunol. 
Immunopathol. 115:369-374. 
3. Brodersen, B., Kelling, C. 1999. Alteration of leukocyte populations in calves 
concurrently infected with bovine respiratory syncytial virus and bovine viral diarrhea 
virus. Viral Immunol. 12:323-334. 
4. Burciaga-Robles, L. O., D. L. Step, C. R. Krehbiel, B. P. Holland, C. J. Richards, 
M. A. Montelongo, A. W. Confer, and R. W. Fulton. 2010. Effects of exposure to 
calves persistently infected with bovine viral diarrhea virus type 1b and subsequent 
infection with Mannheima haemolytica on clinical signs and immune variables: 
model for bovine respiratory disease via viral and bacterial interaction. J. Anim. Sci. 
88:2166-2178. 
5. Cherfils-Vicini, J., S. Platonova, M. Gillard, L. Laurans, P. Validire, R. 
Caliandro, P. Magdeleinat, F. Mami-Chouaib, M.-C. Dieu-Nosjean, W.-H. 
Fridman, D. Damotte, C. Sautès-Fridman, and I. Cremer. 2010. Triggering of 
TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and 
chemoresistance. J. Clin. Invest. 120:1285-1297. 
6. Confer, A. W. 2009. Update on bacterial pathogenesis in BRD. Anim. Health Res. 
Rev. 10:145-148. 
7. Fulton, R. W. 2009. Bovine respiratory disease research (1983-2009). Anim. Health 
Res. Rev. 10:131-139. 
8. Herbeuval, J.-P., A. Boasso, J.-C. Grivel, A. W. Hardy, S. A. Anderson, M. J. 
Dolan, C. Chougnet, J. D. Lifson, and G. M. Shearer. 2005. TNF-related 
apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro 
production by antigen-presenting cells. Blood 105:2458-2464. 
9. Liebler-Tenorio, E. M., J. F. Ridpath, and J. D. Neill. 2004. Distribution of viral 
antigen and tissue lesions in persistent and acute infection with the homologous strain 
of noncytopathic bovine viral diarrhea virus. J. Vet. Diagn. Invest. 16:388-396. 
10. Liebler-Tenorio, E. M., J. F. Ridpath, and J. D. Neill. 2003. Lesions and tissue 
distribution of viral antigen in severe acute versus subclinical acute infection with 
BVDV2. Biologicals 31:119-122. 
11. Ridpath, J. 2010. The contribution of infections with bovine viral diarrhea viruses to 
bovine respiratory disease. Vet. Clin. North. Am. Food Anim. Pract. 26:335-348. 
12. Ridpath, J.F. 2005. Control of BVDV in dairy herds. Hoard's Dairyman 150:509. 
13. Villinger, F., P. E. Rollin, S. S. Brar, N. F. Chikkala, J. Winter, J. B. Sundstrom, 
S. R. Zaki, R. Swanepoel, A. A. Ansari, and C. J. Peters. 1999. Markedly elevated 
levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor 
necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 
179 :S188-191. 
 
 
 
 
